0001214659-19-005219.txt : 20190814 0001214659-19-005219.hdr.sgml : 20190814 20190814100327 ACCESSION NUMBER: 0001214659-19-005219 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 44 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190814 DATE AS OF CHANGE: 20190814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL HEALTH FARM HOLDINGS INC CENTRAL INDEX KEY: 0001621697 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 611744532 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-56028 FILM NUMBER: 191023500 BUSINESS ADDRESS: STREET 1: NO.48 & 49, JALAN VELOX 2 STREET 2: TAMAN VELOX, RAWANG INDUSTRIAL PARK CITY: RAWANG STATE: N8 ZIP: 48000 BUSINESS PHONE: 60(3)60916321 MAIL ADDRESS: STREET 1: NO.48 & 49, JALAN VELOX 2 STREET 2: TAMAN VELOX, RAWANG INDUSTRIAL PARK CITY: RAWANG STATE: N8 ZIP: 48000 FORMER COMPANY: FORMER CONFORMED NAME: AMBER GROUP INC DATE OF NAME CHANGE: 20141007 10-Q 1 nh81219410q.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

(Mark One)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended June 30 2019

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to ______________

 

Commission File No. 000-1621697

 

NATURAL HEALTH FARM HOLDINGS INC.

(Exact name of small business issuer as specified in its charter)

 

NEVADA       98-1032170
(State or other jurisdiction of
incorporation or organization)		       (I.R.S. Employer
Identification No.)

 

No.48 & 49, Jalan Velox 2, Taman Velox, Rawang Industrial Park

48000 Rawang, Selangor, Malaysia

(Address of principal executive offices)

+60(3) 6091 6321

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer o Accelerated filer o
Non-accelerated filer o Smaller reporting company x
Emerging growth company x    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   NHEL   OTC Markets Group

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x

 

The number of shares of Common Stock, $0.001 par value, of the registrant outstanding at August 12, 2019 was 162,186,300.

 

 

 

   
 

 

TABLE OF CONTENTS

 

    Page No.
PART I.  
     
Item 1. Financial Statements. 1
     
  Condensed Balance Sheets as of March 31, 2019 (Unaudited) and September 30, 2018 (Restated) 1
     
  Condensed Statements of Operations for the Three Months and Six Months ended March 31, 2019 and
2018 (Unaudited)		 2
     
  Condensed Statements of Cash Flows for the Six Months ended March 31, 2019 and 2018 (Unaudited) 3
     
  Notes to Unaudited Condensed Financial Statements 4 to 11
     
Item 2 Management’s Discussion and Analysis or Plan of Operation 12
Item 3 Quantitative and Qualitative Disclosure About Market Risks 15
Item 4 Controls and Procedures 15
     
   
PART II    
     
Item 1 Legal Proceedings 16
Item  1A Risk Factors 16
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 16
Item 3 Defaults Upon Senior Securities 16
Item 4 Mine Safety Disclosures 16
Item 5 Other Information 16
Item 6 Exhibits 16
   
SIGNATURES 18
     
EXHIBIT INDEX 19

 

   
 

 

FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (“Form 10-Q”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new products or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties.

 

Forward-looking statements may include the words “may,” “could,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect,” “desire,” “goal,” “should,” “objective,” “seek,” “plan,” “strive” or “anticipate,” as well as variations of such words or similar expressions, or the negatives of these words. These forward-looking statements present our estimates and assumptions only as of the date of this Form 10-Q. Except for our ongoing obligation to disclose material information as required by the federal securities laws, we do not intend, and undertake no obligation, to update any forward-looking statement. We caution readers not to place undue reliance on any such forward-looking statements. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes will likely vary materially from those indicated.

 

   
 

 

PART I.

 

Item 1. Financial Statements

 

NATURAL HEALTH FARM HOLDINGS INC.

CONDENSED BALANCE SHEETS

 

  June 30, 2019   September 30, 2018 
ASSETS  (Unaudited)   (Restated) 
Current Assets        
  Cash and cash equivalents  $868,537   $439,846 
  Account receivables – third parties   454,638    105,018 
  Account receivables – related parties   -    226,548 
  Other receivables and deposits   712,165    95,569 
  Inventories   578,732    - 
  Tax assets   5,714    5,463 
Total Current Assets   2,619,786    872,444 
           
  Property, plant and equipment, net  $795,337   $159,146 
  Goodwill   1,118,843    - 
           
Total Non-Current Assets   1,914,180    159,146 
           
Total Assets  $4,533,966   $1,031,590 
           
LIABILITIES AND EQUITY          
           
Current Liabilities          
  Accounts payable  $163,748   $69,805 
  Accrued expense   738,417    38,499 
  Payable to affiliate   644,794    311,337 
  Deferred revenue – third parties   40,369    48,694 
  Deferred revenue – related parties   30,416    57,341 
  Short term borrowings   381,165    40,000 
  Advances from directors   9,490    11,210 
  Commercial bill   280,360    - 
Total Current Liabilities   2,288,759    576,886 
           
  Deferred tax liabilities – Non-Current liabilities  $8,119   $6,817 
Total Liabilities   2,296,878    583,703 
           
Equity          
Common Stock, $0.001 par value, 500,000,000 shares
authorized, 162,177,000 shares and 161,555,000 shares issued and outstanding
at March 31, 2019 and September 30, 2018, respectively		  $162,279   $161,555 
Additional Paid in Capital   2,562 ,782    857,783 
Accumulated deficit   (1,022,658)   (1,071,993)
Foreign currency translation reserve   (24,596)   (16,758)
Merger reserve   517,300    517,300 
Total equity attributable to owners of the Company   2,195,107    447,887 
           
Non-controlling interests  $41,981   $- 
Total Equity   2,237,088    447,887 
           
Total Liabilities and Equity  $4,533,966   $1,031,590 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 1  
 

 

NATURAL HEALTH FARM HOLDINGS INC.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

  For the Three Months Ended June 30,    For the Six Months Ended June 30, 
  2019   2018   2019   2018 
  (Unaudited)   (Restated)   (Unaudited)   (Restated) 
Revenues – related parties  $656,137   $264,692   $970,676   $480,350 
Revenues – third parties   150,250    9,782    642,752    14,647 
Total Revenues   806,387    274,474    1,613,428    494,997 
                     
Cost of Goods Sold   (256,206)   (121,513)   (596,148)   (242,613)
                     
Gross Profit   550,181    152,961    1,017,280    252,384 
                     
Operating Expenses:                    
  Consulting fees   (43,675)   (109,626)   (117,726)   (145,240)
  Legal and filing fees   (12,300)   (12,130)   (58,165)   (35,845)
  Stock compensation   -   (526,295)   -    (526,295)
  Other general and administrative   (450,688)   (123,892)   (861,375)   (194,474)
Total Operating  and Administrative Expenses   (506,663)   (771,943)   (1,037,266)   (901,854)
                     
Profit/(Loss) from Operations   43,518    (618,982)   (19,986)   (649,470)
                     
Other income   74,271    446    77,764    1,052 
Finance costs   (2,803)   -    (11,036)   - 
                     
Profit/(Loss) Before Provision For Income Tax   114,986    (618,536)   46,742    (648,418)
                     
Provision for income tax   -    -    -    - 
                     
Net Profit/(Loss)  $114,986   $(618,536)  $46,742   $(648,418)
                     
Other comprehensive (expenses)/income                    
                     
Foreign currency translation differences   (16,710)   (37,222)   (1,880)   (2,261)
                     
Total comprehensive income/(expense) for the period  $98,276   $(655,758)  $44,862   $(650,679)
                     
Loss attributable to:                    
Owners of the Company   74,760    (655,758)   49,335    (648,418)
Non-controlling interests   40,226    -    (2,593)   - 
Income /(Loss) for the period  $114,986   $(655,758)  $46,742   $(648,418)
                     
Total comprehensive expense attributable to:                    
Owners of the Company   52,449    (655,758)   41,498    (650,679)
Non-controlling interests   45,827    -    3,364    - 
Total comprehensive income/(expense) for the period  $98,276   $(655,758)  $44,862   $(650,679)
                     
Earnings per share  $-   $-   $-   $- 
                     
Weighted Average Number of Shares
Outstanding - Basic and Diluted		   162,278,405    156,201,374    162,278,405    150,151,000 

 

 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 2  
 

 

NATURAL HEALTH FARM HOLDINGS INC.

CONDENSED STATEMENTS OF CASH FLOWS

 

  For the Nine Months Ended June 30, 
  2019   2018 
  (Unaudited)   (Restated) 
Cash Flows from Operating Activities:        
Net Loss  $46,742   $(648,418)
Adjustment to reconcile net loss to net cash provided by
(used in) operating activities		          
Depreciation and Amortization of plant and equipment   111,836    7,582 
Common stock issued to consultants for services   -    105,000 
Stock compensation expense upon grant of stock options   -    526,295 
Changes in operating assets and liabilities          
Account receivables   (566,261)   (411,104)
Account payables   (69,540)   457,681 
Directors   (1,720)   11,418 
Inventories   (160,838)   - 
           
Net Cash Flows (Used in)/Provided by Operating Activities   (639,781)   48,454 
           
Cash Flows from Investing Activities          
Purchase of plant & equipment   (61,808)   - 
Acquisition of subsidiaries, net of cash and cash equivalents   (1,196,967)   (55,611)
Cash inflows from merger and acquisition, net   -    277,180 
           
Net Cash Flows (Used in)/Provided by Investing Activities   (1,258,775)   221,569 
           
Cash Flows from Financing Activity          
Drawdowns of borrowings, net   621,525    - 
Proceeds from issuance of shares   1,705,722    40,724 
           
Net Cash Flows Provided by Financing Activity   2,327,247    40,724 
           
Net Increase in Cash and Cash Equivalents   428,691    310,747 
           
Cash and Cash Equivalents, Beginning of the Period   439,846    - 
           
Cash and Cash Equivalents, End of the Period  $868,537   $310,747 
           
Supplemental Disclosures of Cash Flow Information:          
Cash paid for Income Taxes  $-   $- 
Cash paid for Interest  $-   $- 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 3  
 

 

NATURAL HEALTH FARM HOLDINGS INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2019

(UNAUDITED)

 

NOTE 1 – NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN

 

Natural Health Farm Holdings Inc. (the “Company”, “We”, “Its”, and “NHEL”) was incorporated under the laws of the State of Nevada on July 10, 2014 (Inception date). The Company has developed web-based business and launched itself into the healthcare industry. The Company has plans to provide through its subsidiaries, retail nutritional supplements, organic foods, personal care, and other health care products. The company has positioned itself to be a fully integrated nutraceutical biotechnology company offering products and related services through healthcare practitioners and direct-to-consumers. The company now owns a research & development laboratory in Malaysia, franchisee management services company and an Australia manufacturing facility producing practitioner only naturopathic and homeopathic medicines.

 

On November 30, 2016, the Company filed a certificate of amendment to its articles of incorporation with the Nevada Secretary of State to change its name from Amber Group Inc. to Natural Health Farm Holdings Inc. and effectuated a 30:1 forward stock split of its common stock and increased its authorized share capital to 500,000,000 (Five Hundred Million). This amendment was unanimously approved by the Company’s board of directors on November 29, 2016, and with the stockholders holding a majority of the Company’s voting power.

 

On March 16, 2017, Financial Industry Regulatory Authority (FINRA) approved the corporate name change to Natural Health Farm Holdings Inc., approved the increase in the Company’s authorized shares of common stock to 500,000,000 shares, and approved 30:1 forward stock split effective March 17, 2017.  The new trading symbol for our common stock is “NHEL”.

 

On January 31, 2018, the company acquired the total outstanding share of NHF International Limited at at nominal value. Upon the completion of the acquisition, its subsidiaries, both Natural Tech R&D Sdn Bhd and NHF Management & Business Sdn Bhd become wholly subsidiaries of the Group. As this transaction is business combination under common control, as deliberated and determined by Directors of the Company, difference between purchase considerations and net tangible assets acquired is recorded in merger reserves which amounted to $517,300. Natural Tech R&D Sdn Bhd, a BioNexus Status Company in Malaysia, specializes in research and development, cultivation, extraction and commercialization of nutraceuticals based on medicinal fungi and NHF Management & Business Sdn Bhd, providing franchisee management services and consultation, such as point-of-sales system, resources, branding and marketing.

 

On December 3, 2018, the Company agreed to purchase 51% of the issued and outstanding capital stock of Prema Life Pty Ltd and 60% of the issued and outstanding capital stock of GGLG Properties Pty Ltd, collectively in exchange for 304,500 shares of the Company’s common stock. On December 28, 2018, the parties mutually agreed to extend the closing date of the purchase transaction on January 1, 2019. The Company issued 304,500 shares of its common stock on December 3, 2018 in good faith for consummating the purchase.

 

The corporate structure is depicted below:

 

 

chart1 

 

 4  
 

 

Basis of Presentation

 

The accompanying interim condensed financial statements are unaudited, but in the opinion of management of the Company, contain all adjustments, which include normal recurring adjustments necessary to present fairly the financial position at June 30, 2019, and the results of operations for three months and six months ended June 30, 2019, and cash flows for the six months ended June 30, 2019 and 2018. The balance sheet as of September 30, 2018 is derived from the Company’s audited financial statements.

 

Certain information and footnote disclosures normally included in financial statements that have been prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission, although management of the Company believes that the disclosures contained in these interim condensed financial statements are adequate to make the information presented therein not misleading. For further information, refer to the financial statements and the notes thereto contained in the Company’s September 30, 2018 Annual Report filed with the Securities and Exchange Commission on Form 10-K on December 28, 2018.

 

Going Concern

   

The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has generated small revenues and has sustained cumulative operating losses since July 10, 2014 (Inception Date) to date and allow it to continue as a going concern. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders and affiliates, the ability of the Company to obtain necessary financing to continue operations, and the attainment of profitable operations. The Company recorded a net cash out flows in operating activities of $639,781 and has an accumulated deficit of $1,022,658 as of June 30, 2019.

 

These factors, among others, raise a substantial doubt regarding the Company’s ability to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying consolidated financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

 5  
 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The following summary of significant accounting policies of the Company is presented to assist in the understanding of the Company’s financial statements. The financial statements and notes are the representation of the Company’s management who is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America (“GAAP”) in all material respects and have been consistently applied in preparing the accompanying financial statements.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related party. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. Company had a cash balance of $868,537 at June 30, 2019 and $439,846 at September 30, 2018, respectively.

 

Property, Plant and Equipment

 

Property, plant and equipment costs include direct costs incurred for purchase of fixed assets and payments made to independent suppliers. The Company accounts for property, plant and equipment costs in accordance with the FASB guidance for the costs of property, plant and equipment to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). As for the computer software costs, they are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Computer software costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to computer software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation.

 

Commencing upon product release, capitalized computer software costs are amortized on the straight-line method over a thirty-six months period. The Company evaluates the future recoverability of capitalized computer software costs on an annual basis.

 

Revenue Recognition and Concentrations

 

We generate revenue from licensing and other software services from our web-based software to distributors and retailers of nutritional supplements in the healthcare industry. We recognize licensing fees and other software services as revenue over the period of the contract at the time that the computer software is delivered and accepted by the customer, the selling price is fixed, and collection is reasonably assured, provided no significant obligations remain. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting.

 

Deferred revenues represent billings or cash received in excess of revenue recognizable on service agreements that are not accounted for as revenues.

 

Through our subsidiaries, Natural Tech R&D Sdn Bhd and Prema Life Pty Ltd, we generate revenue from distributing health supplements,naturopathic medicines and other health food products. Prema Life Pty Ltd also manufactured goods and packaging for contract clients.

 

Concentration of Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company does not have the cash balances in excess of Federal Deposit Insurance Corporation limit at June 30, 2019 and September 30, 2018, respectively.

 

 6  
 

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes” . The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

The Company follows the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions” When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying condensed balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

 

Earnings (Loss) Per Common Share

 

The Company computes net earnings (loss) per share in accordance with ASC 260, “Earnings per Share” . ASC 260 requires presentation of both basic and diluted net earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. At June 30, 2019 and September 30, 2018, there were no convertible notes, options or warrants available for conversion that if exercised, may dilute future earnings per share.

 

Fair value of Financial Instruments and Fair Value Measurements

 

ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

 

Level 1

 

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2

 

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

 

 7  
 

 

Fair value of Financial Instruments and Fair Value Measurements (Continued)

 

Level 3

 

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

The Company’s financial instruments consist principally of cash, accounts payable, accrued expenses and payable to an affiliate. Pursuant to ASC 820, “Fair Value Measurements and Disclosures” and ASC 825, “Financial Instruments”, the fair value of our cash equivalents is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The Company believes that the recorded values of all the other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

 

 

The following table presents assets and liabilities that were measured and recognized at fair value as of March 31, 2019 on a recurring basis:

 

 

Description   Level 1    Level 2    Level 3 
None  $-   $-   $- 

 

The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:

 

 

Description   Level 1    Level 2    Level 3 
None  $-   $-   $- 

 

 

 

Recent Accounting Pronouncements

 

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses (Topic 326).” The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. This ASU is effective for financial statements issued for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating this guidance to determine the impact it may have on its financial statements.

 

In 2015, the FASB issued ASU No. 2015-17, “Income Taxes” (Topic 740): Balance Sheet Classification of Deferred Taxes , which requires all deferred tax assets and liabilities to be classified as noncurrent in a classified balance sheet. Current US GAAP requires an entity to separate deferred tax assets and liabilities into current and noncurrent amounts in a classified balance sheet. For public entities, ASU 2015-17 is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For all other entities, ASU 2015-17 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018, and may be applied either prospectively or retrospectively, with early application permitted for financial statements that have not been previously issued. The Company has not yet determined the effect of the adoption of this standard on the Company’s financial position and results of operations.

 

 8  
 

  

NOTE 3 – PROPERTY, PLANT AND EQUIPMENT

 

The amount capitalized include direct costs and incidental costs incurred in developing the software purchased from the third party.

 

The following table presents details of our property, plant and equipment costs as of June 30, 2019 and September 30, 2018:

 

 

 

Balance at

September 30, 2018

  

Additions through

acquisition of

subsidiaries

   Amortization  

Balance at

June 30, 2019

 
                
Property, plant and equipment, net  $159,146   $712,027   $(111,836)  $759,337 

 

 

Property, plant and equipment costs are being amortized on a straight-line basis over their estimated lives.

 

The future amortization expense of property, plant and equipment costs as of June 30, 2019 are to be recorded in accordance with their estimated useful lives.

 

NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable at June 30, 2019 and September 30, 2018 totaled $163,748 and $69,805, respectively. While the accrued expenses at June 30, 2019 and September 30, 2018 totaled $738,417 and 38,499, respectively.

 

NOTE 5 – PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS

 

The Company has paid $1,720 previously advanced from a director for its working capital (see NOTE 6).

 

The Company was granted short term borrowings from financial institutions for its working capital needs. The short term borrowings received is interest bearing as summarized below:

 

Balance

June 30, 2019

  

Balance

September 30,
2018

 
  (Unaudited)   (Restated) 
Short term borrowings  $381,165   $40,000 
Commercial bills  $280,360   $- 
Total  $661,525   $40,000 

 

On February 15, 2019, the Company executed a convertible promissory note with Power Up Lending Group LTD (the “Power Up”), an unrelated-party, the sum of

$138,888 together with any interest as set forth herein, on February 15, 2020 (the “Maturity Date”), and to pay interest on the unpaid principal balance hereof at the rate of eight percent (8%)(the “Interest Rate”) per annum from the date hereof (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The total consideration received against the Note was $138,888, with the Note bearing $500 as a due diligence fee and $2,500 for legal expenses.

 

On March 12, 2019, , the Company executed another convertible promissory note with Power Up Lending Group LTD (the “Power Up”), the sum of $128,000 together with any interest as set forth herein, on March 12, 2020 (the “Maturity Date”), and to pay interest on the unpaid principal balance hereof at the rate of eight percent (8%)(the “Interest Rate”) per annum from the date hereof (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The total consideration received against the Note was $128,000, with the Note bearing $500 as a due diligence fee and

$2,500 for legal expenses.

 

On March 12, 2019, the Company executed a convertible promissory note with Labrys Fund, LP (the “Labrys”), an unrelated-party, a sum of up to $850,000, bearing an interest rate of 12%, per annum from the date hereof (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise as provided herein. The maturity date of each tranche funded under this convertible promissory note shall be six (6) months from the funding date of the respective tranche (each a “Maturity Date”). The consideration to the Company for this Note is up to $765,000.00 (the “Consideration”) and carries a prorated original issue discount of up to $85,000.00 (the “OID”) Total consideration received of the first tranche was $126,000, including $3,000 for legal expenses. At the closing of the First Tranche, the outstanding principal amount under this Note shall be $140,000.00, consisting of the First Tranche plus the prorated portion of the OID. In connection with the funding of the First Tranche of the Note, the Company shall issue to Labrys, as a commitment fee, 92,105 shares of its common stock (the “First Returnable Shares”), as further provided in the Note, as well as to issue 15,000 shares (the “Commitment Shares”) to Labrys on the Closing Date, as a commitment fee.

 

 9  
 

 

On March 19, 2019, the Company executed a convertible promissory note with Auctus Fund, LLC (the “Auctus”), an unrelated-party, a sum of $350,000, together with any interest as set forth herein, on December 19, 2019 (the “Maturity Date”), and to pay interest on the unpaid principal balance hereof at the rate of twelve percent (12%) (the “Interest Rate”) per annum from the date hereof (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. ). The total consideration received against the Note was $350,000, with the Note bearing $35,000 as a due diligence fee and $2,750 for legal expenses. In connection with the funding of the Note, the Company shall issue to Auctus on the Closing Date, as a commitment fee, 35,000 shares of the Company’s common stock (the “Commitment Shares”), as well as 175,000 shares of its common stock (the “Returnable Shares”, as further provided in the Note). The Returnable Shares and Commitment Shares shall be deemed earned in full as of the Closing Date.

 

The Company’s subsidiary, GGLG Properties Pty Ltd executed an $280,360 (AUD$400,000) commercial bill with National Australia Bank Limited, with a fixed interest rate for each rollover period.

 

NOTE 6 – RELATED PARTY TRANSACTIONS

 

During the financial period under review, the Company paid an amount of $1,720 to the directors of the Company as of June 30, 2019, whilst received an advances of $11,210 from directors for its working capital needs as of September 30, 2018, respectively. Funds advanced to the Company by the director are non- interest bearing, unsecured and due on demand.

 

The Company has received advances for its working capital needs from an affiliate in which the Company’s Chief Executive Officer holds the position of director in such entity (see NOTE 5).

 

As for the sales to related parties, the amounts are disclosed on Condensed Statements Of Operations (PAGE 2).

 

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

Litigation Costs and Contingencies

 

From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Other than as set forth below, management is currently not aware of any such legal proceedings or claims that could have, individually or in the aggregate, a material adverse effect on our business, financial condition, or operating results.

 

In the normal course of business, the Company incurs costs to hire and retain external legal counsel to advise it on regulatory, litigation and other matters. The Company expenses these costs as the related services are received. If a loss is considered probable and the amount can be reasonable estimated, the Company recognizes an expense for the estimated loss.

 

Contingent liabilities that are probable to arise from the recent legal related to the company’s subsidiary Prema Life Pty Ltd, the details are disclosed on Part II, Item 1. Legal Proceedings (Page 16).

 

 10  
 

 

NOTE 8: STOCKHOLDERS’ DEFICIT

 

The Company’s capitalization at June 30, 2019 was 500,000,000 authorized common shares with a par value of $0.001 per share.

 

Common Stock

 

On December 3, 2018, the Company agreed to purchase 51% of the issued and outstanding capital stock of Prema Life Pty Ltd and 60% of the issued and outstanding capital stock of GGLG Properties PTY Ltd, collectively in exchange for 304,500 shares of the Company’s common stock valued at $1,218,000 based on the fair value of the common stock on the closing date. On December 28, 2018, the parties mutually agreed to extend the closing of the purchase transaction on January 1, 2019. The Company issued 304,500 shares of its common stock on December 3, 2018 in good faith for consummating the purchase. The Company has recorded the fair value of the common stock issued as stock subscriptions receivable at December 31, 2018.

 

On March 12, 2019, the Company executed a convertible promissory note with Labrys Fund, LP (the “Labrys”). In connection with the funding of the First Tranche of the Note, the Company shall issue to Labrys, as a commitment fee, 92,105 shares of its common stock (the “First Returnable Shares”), as further provided in the Note, as well as to issue 15,000 shares (the “Commitment Shares”) to Labrys on the Closing Date, as a commitment fee.

 

On March 19, 2019, the Company executed a convertible promissory note with Auctus Fund, LLC (the “Auctus”). In connection with the funding of the Note, the Company shall issue to Auctus on the Closing Date, as a commitment fee, 35,000 shares of the Company’s common stock (the “Commitment Shares”), as well as 175,000 shares of its common stock (the “Returnable Shares”, as further provided in the Note). The Returnable Shares and Commitment Shares shall be deemed earned in full as of the Closing Date.

 

On March 20, 2019, the company executed a convertible promissory note with EMA Financial, LLC (the “EMA”). In connection with the funding of the First Tranche of the Note, the Company shall issue to EMA, 15,000 shares of restricted common stock as a commitment fee the “Commitment Shares”), as well as 86,800 shares of restricted common stock (the “Returnable Shares”), as further provided in the Note). In the event the Company fails to redeem the tranche by its maturity date the Returnable Shares shall not be returned to the Company

 

As a result of all common stock issuances, the Company had 162,278,405 shares and 161,555,000 shares of common stock issued and outstanding at June 30, 2019 and September 30, 2018, respectively.

 

NOTE 9 – SUBSEQUENT EVENTS  

 

Management has evaluated subsequent events through August 14 , 2019, the date the financial statements were available to be issued, noting no items that would impact the accounting for events or transactions in the current period except for:

 

·On July 2, 2019 and August 2, 2019, the Company settled the remaining balances of the convertible promissory note in full for total $140,000 to Labrys Fund, LP, the 92,105 returnable shares was returned to company on August 7, 2019;

 

·On July 3, 2019 and July 29, 2019 the Company settled the remaining balances of the convertible promissory note in full for total $350,000 to Auctus Fund, LLC. The arrangement with Auctus to return the returnable shares of 175,000 is in progress; and

 

·On July 5, 2019 and July 31, 2019, the Company settled the remaining balances of the convertible promissory note in full for total $266,000 to Power Up Lending Group LTD.

  

 11  
 

 

Item 2. Management’s Discussion and Analysis or Plan of Operation

 

This Quarterly Report Form 10-Q contains forward-looking statements. Our actual results could differ materially from those set forth as a result of general economic conditions and changes in the assumptions used in making such forward-looking statements. The following discussion and analysis of our financial condition and results of operations should be read together with the unaudited condensed financial statements and accompanying notes and the other financial information appearing elsewhere in this report. The analysis set forth below is provided pursuant to applicable Securities and Exchange Commission regulations and is not intended to serve as a basis for projections of future events.

 

Natural Health Farm Holdings Inc., incorporated in the State of Nevada on July 10, 2014 (inception date), has developed and launched itself into the healthcare industry. The company started as a nutritional consulting service provider by offering a web based naturopathic learning management system that allows distributors, chiropractors and consumers to be educated on health-related aspects of various diseases. The company has positioned itself to be a fully integrated nutraceutical biotechnology company offering products and related services through healthcare practitioners and direct-to-consumers. The company now owns a research & development laboratory in Malaysia, franchisee management services company and an Australia manufacturing facility producing practitioner only naturopathic and homeopathic medicines.

 

On January 31, 2018, the company acquired the total outstanding share of NHF International Limited at USD$1. Upon the completion of the acquisition, its subsidiaries, both Natural Tech R&D Sdn Bhd and NHF Management & Business Sdn Bhd become wholly subsidiaries of the Group. As this transaction is business combination under common control, as deliberated and determined by Directors of the Company, difference between purchase considerations and net tangible assets acquired is recorded in merger reserves which amounted to $517,300. Natural Tech R&D Sdn Bhd, a BioNexus Status Company in Malaysia, specializes in research and development, cultivation, extraction and commercialization of nutraceuticals based on medicinal fungi and NHF Management & Business Sdn Bhd, providing franchisee management services and consultation, such as point-of-sales system, resources, branding and marketing.

 

On December 3, 2018, the Company agreed to purchase 51% of the issued and outstanding capital stock of Prema Life Pty Ltd and 60% of the issued and outstanding capital stock of GGLG Properties Pty Ltd, collectively in exchange for 304,500 shares of the Company’s common stock. On December 28, 2018, the parties mutually agreed to extend the closing date of the purchase transaction on January 1, 2019. The Company issued 304,500 shares of its common stock on December 3, 2018 in good faith for consummating the purchase.

 

Prema Life Pty Ltd is a manufacturer and supplier of functional foods, vitamins and supplements, of practitioner only naturopathic and homeopathic medicines in Australia. The Company hosts regular educational webinars and seminars for practitioners to learn about the natural products. The Company operates from a Hazard Analysis and Critical Control Point (“HACCP”) certified manufacturing facility and has the capacity to produce a wide range of powder and liquid products to requirements.

 

GGLG Properties Pty Ltd. owns industrial property and factory at Brendale in Brisbane, Queensland, Australia. The Company leases this property to Prema Life Pty Ltd, and incurs costs in connection with owning and maintaining that property and recovers these costs through rental charges and rental recoveries pursuant to a long-term lease.

 

We anticipate that we will need substantial working capital over the next 12 months to continue as a going concern and to expand our business. Our independent auditors have expressed substantial doubt as to the ability of the Company to continue as a going concern. We intend to make an equity offering of our common stock for the acquisition and operation expenses. If we cannot raise the required cash, we will issue additional shares of our common stock in lieu of cash.

 

Results of Operations

 

Our results of operations for the three months ended June 30, 2019 and 2018 included the operations of the Company, NHF International and its subsidiaries as a common control situation, and both Prema Life Pty Ltd and GGLG Properties Pty Ltd from January 1, 2019.

 

For the three months ended June 30, 2019 and 2018, we recorded total revenues of $806,387 ($656,137 from related parties and $150,249 from third parties) and $274,474 ($264,692 from related parties and $9,782 from third parties) respectively. Revenues recorded were earned by supplying manufactured goods, selling supplements, providing laboratory testing services and providing franchisee and marketing consultation. Cost of goods sold recorded was $256,206 and $121,513, for the three months ended June 30, 2019 and 2018, respectively.

 

For the nine months ended June 30, 2019 and 2018, we recorded total revenues of $1,613,428 ($970,676 from related parties and $642,752 from third parties) and $494,997 ($480,350 from related parties and $14,647 from third parties), respectively. Revenues recorded were earned by supplying manufactured goods, selling supplements, providing laboratory testing services and providing franchisee and marketing consultation. Cost of goods sold of $596,148 and $242,613, for the nine months ended June 30, 2019 and 2018, respectively.

 

 12  
 

 

Operating expenses for the three months ended June 30, 2019 and 2018 were $506,663 and $771,943, respectively. Operating expenses for the three months ended June 30, 2019, consisted of the Company recording consulting fees of $43,675 payable to consultants and business advisors for services, $12,300 in legal and filing fees, and $450,688 in other general and administrative expenses. Operating expenses for the three months ended June 30, 2018, consisted of $109,626 in fees paid to professional consultants and business advisors for services, $12,130 in legal and filing fees, stock compensation expense of $526,295 for grant of options to employees, directors and consultants, and $123,892 in other general and administrative expenses.

 

Operating expenses for the nine months ended June 30, 2019 and 2018 were $1,037,266 and $901,854, respectively. Operating expenses for the nine months ended June 30, 2019 consisted of the Company engaging consultants and business advisors for consulting fees totaling $117,725, legal and filing fees of $58,165 upon becoming a public reporting entity, and $861,375 in other general and administrative expenses. Operating expenses for the nine months ended June 30, 2018 consisted of the Company engaging consultants and business advisors for consulting fees totaling $145,240, legal and filing fees of $35,845 upon becoming a public reporting entity, stock compensation expense of $526,295 for grant of stock options to employees, directors and consultants, and $194,474 in other general and administrative expenses.

 

As a result of the above, we reported a net profit of $114,986 and a net loss of $618,536 for the three months ended June 30, 2019 and 2018, while reported a net profit of $46,742 and a net loss of $648,418 for the nine months ended June 30, 2019 and 2018, respectively.

 

Liquidity and Capital Resources

 

Cash and cash equivalents were $838,120 at June 30, 2019 as compared to $439,846 at September 30, 2018. As reported in the accompanying financial statements, we recorded a net profit of $46,742 for the nine months ended June 30, 2019. Our accumulated deficit at June 30, 2019 was $1,022,658. These factors and our ability to raise additional capital to accomplish our objectives, raises doubt about our ability to continue as a going concern. We expect our expenses will continue to increase during the foreseeable future as a result of increased operational expenses and the development of our current business operations. Consequently, we are dependent on the proceeds from future debt or equity investments to sustain our operations and implement our business plan. If we are unable to raise sufficient capital, we will be required to delay or forego some portion of our business plan, which would have a material adverse effect on our anticipated results from operations and financial condition. There is no assurance that we will be able to obtain necessary amounts of capital or that our estimates of our capital requirements will prove to be accurate.

 

We presently do not have any significant credit available, bank financing or other external sources of liquidity. Due to our accumulated operating losses, our operations have not been a source of liquidity. We will need to acquire other profitable entities or obtain additional capital in order to expand operations and become profitable. In order to obtain capital, we may need to sell additional shares of our common stock or borrow funds from private lenders. There can be no assurance that we will be successful in obtaining additional funding.

 

To the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of such securities may result in dilution to existing stockholders. If additional funds are raised through the issuance of debt securities, these securities may have rights, preferences and privileges senior to holders of common stock and the terms of such debt could impose restrictions on our operations. Regardless of whether our cash assets prove to be inadequate to meet our operational needs, we may seek to compensate providers of services by issuance of stock in lieu of cash, which may also result in dilution to existing shareholders. Even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing.

 

No assurance can be given that sources of financing will be available to us and/or that demand for our equity/debt instruments will be sufficient to meet our capital needs, or that financing will be available on terms favorable to us. If funding is insufficient at any time in the future, we may not be able to take advantage of business opportunities or respond to competitive pressures or may be required to reduce the scope of our planned service development and marketing efforts, any of which could have a negative impact on our business and operating results.

 

Operating Activities

 

Net cash flows provided by operating activities for the nine months ended June 30, 2019, was a negative $668,479, which resulted from our net profit of 46,742, depreciation costs of $111,836, and a net change in operating assets of a negative $827,056. Net cash flows used in operating activities for the nine months ended June 30, 2018 was $48,454 which resulted primarily from our net loss of $648,418, amortization of software costs of $7,582, common stock valued at $105,000 issued to consultants for business advisory services, stock compensation expense of $526,295 for grant of stock options to employees, directors and consultants, and a net change in operating liabilities of 57,995.

 

 13  
 

 

Investing Activities:

 

Net cash flows used in investing activities for the nine months ended June 30, 2019 was primarily due to the acquisition of Prema Life Pty Ltd and GGLG Properties Pty Ltd of $1,196,967 and purchase of equipment of $61,808. Net cash flows used in investing activities for the nine months ended June 30, 2018 were primarily due to the purchase of plant & equipment of $55,611 and cash inflow from merger and acquisition of 277,180.

 

Financing Activities

 

Net cash flows provided by financing activities for the nine months ended June 30, 2019 was $2,325,527, consisting of cash advances from Directors $1,720, drawdowns of borrowings $621,525 and proceeds from issuance of shares $1,705,722. Net cash flows provided by financing activities for the nine months ended June 30, 2018 was $40,724, consisting of cash received from shareholders for stock subscription.

 

As a result of the above activities, we experienced a net increase in cash of $838,120 and $310,747 for the nine months ended June 30, 2019 and 2018, respectively. We expect that working capital will continue to be funded through a combination of our existing sales and further issuance of securities or obtaining financing. Our ability to continue as a going concern is still dependent on our success in obtaining additional financing from investors or from sale of our common shares.

 

Critical Accounting Policies and Significant Judgments and Estimates

 

Our management’s discussion and analysis of our financial condition and results of operations is based on our financial statements which we have prepared in accordance with U.S. generally accepted accounting principles. In preparing our financial statements, we are required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. We have identified the following accounting policies that we believe require application of management’s most subjective judgments, often requiring the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Our actual results could differ from these estimates and such differences could be material.

 

While our significant accounting policies are described in more details in Note 2 of our annual financial statements included in our Annual Report filed with the SEC on December 28, 2017, we believe the following accounting policies to be critical to the judgments and estimates used in the preparation of our financial statements.

 

JOBS Act Accounting Election

 

We are an “emerging growth company,” as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards, and, therefore, will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.

 

Fair value of Financial Instruments and Fair Value Measurements

 

ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

 

Off-Balance Sheet Arrangements

 

We have not engaged in any off-balance sheet arrangements as defined in Item 303(c) of the SEC’s Regulation S-B. We did not have any relationships with unconsolidated organizations or financial partnerships, such as structured finance or special-purpose entities that would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

 

Recent Accounting Pronouncements

 

We have implemented all new accounting pronouncements that are in effect and that may impact our financial statements and do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations.

 

 14  
 

 

Item 3.Quantitative and Qualitative Disclosures About Market Risks.

 

Not Applicable.

 

Item 4.Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

We carried out an evaluation of the effectiveness of disclosure controls and procedures as of the end of the period covered by this report under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures as of March 31, 2018 were not effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. The term “disclosure controls and procedures,” as defined under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures. Notwithstanding the identified material weaknesses, management believes the financial statements included in this quarterly report on Form 10-Q fairly represent in all material respects our financial condition, results of operations and cash flows at and for the periods presented in accordance with U.S. GAAP.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 under the Exchange Act that occurred during the three months ended March 31, 2018, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 15  
 

 

PART II

 

 

Item 1.Legal Proceedings.

 

On 25 January 2019, Craig Popplestone obtained default judgment in Magistrates Court of Queensland proceedings no. M205, M206 and M207 (Magistrates Court Proceedings) against Prema Life Pty Ltd for alleged unpaid invoices. The default judgments were irregularly obtained on the basis that the Uniform Civil Procedure Rules 1999 have not been complied with and Prema Life Pty Ltd was never served with any document filed in the proceedings. The irregular Default Judgments were set aside by the Magistrates Court on 21 June 2019. Prema Life Pty Ltd has a defence to the proceeding on the basis that the parties entered into a Deed of Release in respect of the debt and accordingly, no debt is owed by Prema Life Pty Ltd to Mr Popplestone. Mr Popplestone has until 19 July 2019 to file any claim and statement of claim in the proceeding should he elect to pursue his claim against Prema Life Pty Ltd. To date no such claim and statement of claim has been served on Prema Life Pty Ltd.

 

On 11 March 2019, Mr Popplestone served a statutory demand on Prema Life Pty Ltd demanding payment of Australian Dollar 49,733 (approximately $34,500),the amount owed pursuant to the default judgments awarded in the Magistrates Court Proceedings. On 1 April 2019, Prema Life Pty Ltd filed an application in the Supreme Court of Queensland proceeding no. 3472 of 2019 seeking to have the statutory demand set aside due to the statutory demand being defective and on the basis that there is a genuine dispute about the nature of the debt. The proceeding has been adjourned to a date to be agreed to by the parties post the hearing of the application to have the default judgments obtained in the Magistrates Court Proceedings set aside as once these default judgments are set aside there will be no debt able to be relied upon by Mr Popplestone for the purpose of the statutory demand.

 

 

On March 6, 2019, the company has executed a term sheet t acquire a majority interest in Biodelta (Pty) Ltd (“Biodelta”) and on May 14, 2019, announced termination of the term sheet. The company is investigating the indebtedness of Biodelta regarding the repayment of refundable deposit of $160,000 for the acquisition of the shares and other business assets in Biodelta. Biodelta failed or neglected to repay the funds on demand when the transaction did not occur. A letter of demand has been issued on May 22, 2019 and June 17, 2019 respectively against Biodelta which Biodelta disputes the obligation to repay. The decision has been made to pursue both civil and criminal proceedings against Biodelta and its director Leon Giese. The legal representative has been authorized to travel to South Africa to commence the proceedings.

 

Item 1A.Risk Factors.

 

Not Applicable

 

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3.Defaults Upon Senior Securities.

 

 None 

 

Item 4.Mine Safety Disclosures.

 

None

 

Item 5.Other Information.

 

None

 

 

 16  
 

 

Item 6.Exhibits.

 

 (a) Exhibits.

 

Exhibit   Item
     
31.1   Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 17  
 

 

SIGNATURES

 

 

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

 

  Natural Health Farm Holdings Inc.
   
Date: August 14, 2019 /s/ Tee Chuen Meng
 

Tee Chuen Meng, President

(Principal Executive Officer and Principal Accounting Officer)

 

 18  
 

 

EXHIBIT INDEX

 

Exhibit   Item
     
31.1   Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

19

 

 

 

 EX-31.1 2 ex31_1.htm EXHIBIT 31.1

 

EXHIBIT 31.1

 

CERTIFICATION

 

I, Tee Chuen Meng, certify that:

 

1. I have reviewed this report on Form 10-Q of Natural Health Farm Holdings Inc. (“Registrant) for the quarter ended June 30, 2019
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
   
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  c. disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

 

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

  a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
     
  b. any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

  /s/ Tee Chuen Meng
  Tee Chuen Meng
  President (Principal Executive Officer)
   
 

August 14, 2019

  

 

 

 

 

 EX-31.2 3 ex31_2.htm EXHIBIT 31.2

 

EXHIBIT 31.2

 

CERTIFICATION

 

I, Tee Chuen Hau, certify that:

 

1. I have reviewed this report on Form 10-Q of Natural Health Farm Holdings Inc. (“Registrant”) for the quarter ended June 30, 2019;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
   
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have:

 

  a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  c. disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

 

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing the equivalent functions):

 

  a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
     
  b. any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

  

 

/s/ Tee Chuen Hau

  Tee Chuen Hau, Chief Financial Officer
  (Principal Accounting Officer)
   
 

August 14, 2019

  

 

 

 

 EX-32.1 4 ex32_1.htm EXHIBIT 32.1

 

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the report of Natural Health Farm Holdings Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned’s, in the capacities and on the dates indicated below, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

  /s/ Tee Chuen Meng
  Tee Chuen Meng
  President (Principal Executive Officer)
  August 14, 2019
   
   /s/Tee Chuen Hau
   Tee Chuen Hau
  Chief Financial Officer (Principal Accounting Officer)
  August 14, 2019

   

 

 

 

 

 

 GRAPHIC 5 chart1.jpg GRAPHIC begin 644 chart1.jpg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end EX-101.INS 6 nhel-20190630.xml XBRL INSTANCE FILE 0001621697 2018-09-30 0001621697 2017-10-01 2018-06-30 0001621697 2018-04-01 2018-06-30 0001621697 2019-06-30 0001621697 2018-06-30 0001621697 2019-04-01 2019-06-30 0001621697 2018-10-01 2019-06-30 0001621697 us-gaap:FairValueInputsLevel1Member 2019-06-30 0001621697 us-gaap:FairValueInputsLevel2Member 2019-06-30 0001621697 us-gaap:FairValueInputsLevel3Member 2019-06-30 0001621697 us-gaap:FairValueInputsLevel1Member 2018-09-30 0001621697 us-gaap:FairValueInputsLevel2Member 2018-09-30 0001621697 us-gaap:FairValueInputsLevel3Member 2018-09-30 0001621697 2018-12-01 2018-12-03 0001621697 nhel:PremaLifePtyLtdMember 2018-12-01 2018-12-03 0001621697 nhel:GGLGPropertiesPTYLtdMember 2018-12-01 2018-12-03 0001621697 nhel:ConvertiblePromissoryNoteMember nhel:EMAFinancialLLCMember us-gaap:ShareBasedCompensationAwardTrancheOneMember nhel:FirstReturnableSharesMember us-gaap:RestrictedStockMember 2019-03-18 2019-03-20 0001621697 nhel:ConvertiblePromissoryNoteMember nhel:EMAFinancialLLCMember us-gaap:ShareBasedCompensationAwardTrancheOneMember nhel:CommitmentSharesMember us-gaap:RestrictedStockMember 2019-03-18 2019-03-20 0001621697 nhel:ConvertiblePromissoryNoteMember nhel:AuctusFundLLCMember us-gaap:ShareBasedCompensationAwardTrancheOneMember nhel:FirstReturnableSharesMember 2019-03-18 2019-03-19 0001621697 nhel:ConvertiblePromissoryNoteMember nhel:AuctusFundLLCMember us-gaap:ShareBasedCompensationAwardTrancheOneMember nhel:CommitmentSharesMember 2019-03-18 2019-03-19 0001621697 nhel:ConvertiblePromissoryNoteMember nhel:LabrysFundLPMember us-gaap:ShareBasedCompensationAwardTrancheOneMember nhel:CommitmentSharesMember 2019-03-11 2019-03-12 0001621697 nhel:ConvertiblePromissoryNoteMember nhel:LabrysFundLPMember us-gaap:ShareBasedCompensationAwardTrancheOneMember nhel:FirstReturnableSharesMember 2019-03-11 2019-03-12 0001621697 2016-11-29 2016-11-30 0001621697 nhel:GGLGPropertiesPtyLtd1Member 2018-12-03 0001621697 nhel:PremaLifePtyLtd2Member 2018-12-02 2018-12-03 0001621697 2018-12-02 2018-12-03 0001621697 nhel:PowerUpLendingGroupLTDMember nhel:ConvertiblePromissoryNoteMember 2019-02-15 0001621697 nhel:PowerUpLendingGroupLTDMember nhel:ConvertiblePromissoryNoteMember 2019-03-12 0001621697 nhel:LabrysFundLPMember nhel:ConvertiblePromissoryNoteMember 2019-03-12 0001621697 nhel:AuctusFundLLCMember nhel:ConvertiblePromissoryNoteMember 2019-03-19 0001621697 nhel:PowerUpLendingGroupLTDMember nhel:ConvertiblePromissoryNoteMember 2019-02-13 2019-02-15 0001621697 nhel:PowerUpLendingGroupLTDMember nhel:ConvertiblePromissoryNoteMember 2019-03-11 2019-03-12 0001621697 nhel:AuctusFundLLCMember nhel:ConvertiblePromissoryNoteMember 2019-03-18 2019-03-19 0001621697 nhel:LabrysFundLPMember nhel:ConvertiblePromissoryNoteMember 2019-03-11 2019-03-12 0001621697 nhel:LabrysFundLPMember nhel:ConvertiblePromissoryNoteMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-03-11 2019-03-12 0001621697 nhel:LabrysFundLPMember nhel:ConvertiblePromissoryNoteMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-03-12 0001621697 2019-08-12 0001621697 nhel:GGLGPropertiesPTYLtdMember nhel:NationalAustraliaBankLimitedMember 2019-06-30 0001621697 nhel:GGLGPropertiesPTYLtdMember nhel:NationalAustraliaBankLimitedMember currency:AUD 2019-06-30 0001621697 nhel:PremaLifePtyLtdMember 2018-12-03 0001621697 us-gaap:SubsequentEventMember nhel:ConvertiblePromissoryNoteMember nhel:LabrysFundLPMember nhel:ReturnableSharesMember 2019-08-06 2019-08-07 0001621697 us-gaap:SubsequentEventMember nhel:ConvertiblePromissoryNoteMember nhel:AuctusFundLLCMember nhel:ReturnableSharesMember 2019-06-29 2019-07-03 0001621697 us-gaap:SubsequentEventMember nhel:ConvertiblePromissoryNoteMember nhel:AuctusFundLLCMember nhel:ReturnableSharesMember 2019-07-27 2019-07-29 0001621697 us-gaap:SubsequentEventMember nhel:ConvertiblePromissoryNoteMember nhel:LabrysFundLPMember nhel:ReturnableSharesMember 2019-07-02 0001621697 us-gaap:SubsequentEventMember nhel:ConvertiblePromissoryNoteMember nhel:LabrysFundLPMember nhel:ReturnableSharesMember 2019-08-02 0001621697 us-gaap:SubsequentEventMember nhel:ConvertiblePromissoryNoteMember nhel:AuctusFundLLCMember nhel:ReturnableSharesMember 2019-07-03 0001621697 us-gaap:SubsequentEventMember nhel:ConvertiblePromissoryNoteMember nhel:AuctusFundLLCMember nhel:ReturnableSharesMember 2019-07-29 0001621697 us-gaap:SubsequentEventMember nhel:ConvertiblePromissoryNoteMember nhel:PowerUpLendingGroupLTDMember 2019-07-05 0001621697 us-gaap:SubsequentEventMember nhel:ConvertiblePromissoryNoteMember nhel:PowerUpLendingGroupLTDMember 2019-07-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:AUD 1031590 4533966 40226 -2593 526295 526295 159146 1914180 1118843 159146 795337 872444 2619786 5463 5714 578732 95569 712165 226548 105018 454638 439846 868537 310747 583703 2296878 6817 8119 576886 2288759 11210 9490 40000 381165 57341 30416 48694 40369 311337 644794 38499 738417 69805 163748 161555 162279 1031590 4533966 447887 2237088 41981 447887 2195107 517300 517300 517300 -16758 -24596 -1071993 -1022658 857783 2562782 0.001 0.001 500000000 500000000 161555000 162177000 161555000 162177000 252384 152961 550181 1017280 242613 121513 256206 596148 494997 274474 806387 1613428 14647 9782 150250 642752 480350 264692 656137 970676 -648418 -618536 114986 46742 -648418 -618536 114986 46742 1052 446 74271 77764 -649470 -618982 43518 -19986 2803 11036 -2261 -37222 -16710 -1880 -650679 -655758 98276 44862 150151000 156201374 162278405 162278405 -45827 -3364 650679 655758 -52449 -41498 -648418 -655758 114986 46742 -648418 -655758 74760 49335 48454 -639781 160838 457681 -69540 411104 566261 310747 428691 40724 2327247 40724 1705722 621525 221569 -1258775 277180 55611 1196967 61808 7582 111836 NATURAL HEALTH FARM HOLDINGS INC Common Stock, par value $0.001 per share 000-1621697 0001621697 10-Q NHEL 2019-06-30 false --09-30 Yes Non-accelerated Filer Q3 2019 <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>NOTE 1 &#8211; NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">Natural Health Farm Holdings Inc. (the &#8220;Company&#8221;, &#8220;We&#8221;, &#8220;Its&#8221;, and &#8220;NHEL&#8221;) was incorporated under the laws of the State of Nevada on July 10, 2014 (Inception date). The Company has developed web-based business and launched itself into the healthcare industry. The Company has plans to provide through its subsidiaries, retail nutritional supplements, organic foods, personal care, and other health care products. The company has positioned itself to be a fully integrated nutraceutical biotechnology company offering products and related services through healthcare practitioners and direct-to-consumers. The company now owns a research &amp; development laboratory in Malaysia, franchisee management services company and an Australia manufacturing facility producing practitioner only naturopathic and homeopathic medicines.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">On November 30, 2016, the Company filed a certificate of amendment to its articles of incorporation with the Nevada Secretary of State to change its name from Amber Group Inc. to Natural Health Farm Holdings Inc. and effectuated a 30:1 forward stock split of its common stock and increased its authorized share capital to 500,000,000 (Five Hundred Million).&nbsp;This amendment was unanimously approved by the Company&#x2019;s board of directors on November 29, 2016, and with the stockholders holding a majority of the Company&#x2019;s voting power.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">On March 16, 2017, Financial Industry Regulatory Authority (FINRA) approved the corporate name change to Natural Health Farm Holdings Inc., approved the increase in the Company&#x2019;s authorized shares of common stock to 500,000,000 shares, and approved 30:1 forward stock split effective March 17, 2017.&nbsp; The new trading symbol for our common stock is &#8220;NHEL&#8221;.</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">On January 31, 2018, the company acquired the total outstanding share of NHF International Limited at at nominal value. Upon the completion of the acquisition, its subsidiaries, both Natural Tech R&amp;D Sdn Bhd and NHF Management &amp; Business Sdn Bhd become wholly subsidiaries of the Group. As this transaction is business combination under common control, as deliberated and determined by Directors of the Company, difference between purchase considerations and net tangible assets acquired is recorded in merger reserves which amounted to $517,300. Natural Tech R&amp;D Sdn Bhd, a BioNexus Status Company in Malaysia, specializes in research and development, cultivation, extraction and commercialization of nutraceuticals based on medicinal fungi and NHF Management &amp; Business Sdn Bhd, providing franchisee management services and consultation, such as point-of-sales system, resources, branding and marketing.</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">On December 3, 2018, the Company agreed to purchase 51% of the issued and outstanding capital stock of Prema Life Pty Ltd and 60% of the issued and outstanding capital stock of GGLG Properties Pty Ltd, collectively in exchange for 304,500 shares of the Company&#x2019;s common stock. On December 28, 2018, the parties mutually agreed to extend the closing date of the purchase transaction on January 1, 2019. The Company issued 304,500 shares of its common stock on December 3, 2018 in good faith for consummating the purchase.</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The corporate structure is depicted below:</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong><u>Basis of Presentation</u></strong></p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The accompanying interim condensed financial statements are unaudited, but in the opinion of management of the Company, contain all adjustments, which include normal recurring adjustments necessary to present fairly the financial position at June 30, 2019, and the results of operations for three months and six months ended June 30, 2019, and cash flows for the six months ended June 30, 2019 and 2018. The balance sheet as of September 30, 2018 is derived from the Company&#x2019;s audited financial statements.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px; text-indent: 27.5pt;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">Certain information and footnote disclosures normally included in financial statements that have been prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission, although management of the Company believes that the disclosures contained in these interim condensed financial statements are adequate to make the information presented therein not misleading. For further information, refer to the financial statements and the notes thereto contained in the Company&#x2019;s September 30, 2018 Annual Report filed with the Securities and Exchange Commission on Form 10-K on December 28, 2018.</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong><u>Going Concern</u></strong></p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;&nbsp;&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The Company&#x2019;s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has generated small revenues and has sustained cumulative operating losses since July 10, 2014 (Inception Date) to date and allow it to continue as a going concern. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders and affiliates, the ability of the Company to obtain necessary financing to continue operations, and the attainment of profitable operations. The Company recorded a net cash out flows in operating activities of $639,781 and has an accumulated deficit of $1,022,658 as of June 30, 2019.<!-- Field: Page; Sequence: 7 --> <!-- Field: /Page --></p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">These factors, among others, raise a substantial doubt regarding the Company&#x2019;s ability to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying consolidated financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">The following summary of significant accounting policies of the Company is presented to assist in the understanding of the Company&#x2019;s financial statements. The financial statements and notes are the representation of the Company&#x2019;s management who is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) in all material respects and have been consistently applied in preparing the accompanying financial statements.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong><u>Use of Estimates</u></strong></p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related party. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company&#x2019;s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong><u>Cash and Cash Equivalents</u></strong></p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. Company had a cash balance of $868,537 at June 30, 2019 and $439,846 at September 30, 2018, respectively.</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong><u>Property, Plant and Equipment</u></strong></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">Property, plant and equipment costs include direct costs incurred for purchase of fixed assets and payments made to independent suppliers. The Company accounts for property, plant and equipment costs in accordance with the FASB guidance for the costs of property, plant and equipment to be sold, leased, or otherwise marketed (&#8220;ASC Subtopic 985-20&#8221;). As for the computer software costs, they are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Computer software costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to computer software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered 'research and development&#x2019; that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">Commencing upon product release, capitalized computer software costs are amortized on the straight-line method over a thirty-six months period. The Company evaluates the future recoverability of capitalized computer software costs on an annual basis.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong><u>Revenue Recognition and Concentrations</u></strong></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">We generate revenue from licensing and other software services from our web-based software to distributors and retailers of nutritional supplements in the healthcare industry. We recognize licensing fees and other software services as revenue over the period of the contract at the time that the computer software is delivered and accepted by the customer, the selling price is fixed, and collection is reasonably assured, provided no significant obligations remain. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">Deferred revenues represent billings or cash received in excess of revenue recognizable on service agreements that are not accounted for as revenues.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Through our subsidiaries, Natural Tech R&#38;D Sdn Bhd and Prema Life Pty Ltd, we generate revenue from distributing health supplements, naturopathic medicines and other health food products. Prema Life Pty Ltd also manufactured goods and packaging for contract clients.</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong><u>Concentration of Risk</u></strong></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company does not have the cash balances in excess of Federal Deposit Insurance Corporation limit at June 30, 2019 and September 30, 2018, respectively.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong><u>Income Taxes</u></strong></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, &#8220;<em>Income Taxes&#8221;</em> . The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">The Company follows the provisions of ASC 740-10, &#8220;<em>Accounting for Uncertain Income Tax Positions</em>&#8221; When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying condensed balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong><u>Earnings (Loss) Per Common Share</u></strong></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">The Company computes net earnings (loss) per share in accordance with ASC 260, &#8220;<em>Earnings per Share&#8221;</em> . ASC 260 requires presentation of both basic and diluted net earnings per share (&#8220;EPS&#8221;) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. At June 30, 2019 and September 30, 2018, there were no convertible notes, options or warrants available for conversion that if exercised, may dilute future earnings per share.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong><u>Fair value of Financial Instruments and Fair Value Measurements</u></strong></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">ASC 820, &#8220;<em>Fair Value Measurements and Disclosures&#8221;,</em> requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument&#x2019;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><em>Level 1</em></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><em>Level 2</em></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><em>Level 3</em></p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><em>&#160;</em></p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">The Company&#x2019;s financial instruments consist principally of cash, accounts payable, accrued expenses and payable to an affiliate. Pursuant to ASC 820, &#8220;<em>Fair Value Measurements and Disclosures&#8221;</em> and ASC 825, &#8220;<em>Financial Instruments&#8221;</em>, the fair value of our cash equivalents is determined based on &#8220;Level 1&#8221; inputs, which consist of quoted prices in active markets for identical assets. The Company believes that the recorded values of all the other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">The following table presents assets and liabilities that were measured and recognized at fair value as of March 31, 2019 on a recurring basis:</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif"> <tr style="vertical-align: bottom"> <td style="width: 55%; border-bottom: black 1pt solid; text-align: center">Description</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff"> <td style="padding-bottom: 1pt">None</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt">&#160;</td> </tr> </table> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:</p> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif"> <tr style="vertical-align: bottom"> <td style="width: 55%; padding-bottom: 1pt; text-align: center">Description</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid">&#160;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid">&#160;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid">&#160;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff"> <td style="padding-bottom: 1pt">None</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt">&#160;</td> </tr> </table> <p style="text-align: justify; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong><u>Recent Accounting Pronouncements</u></strong></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">In June 2016, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, &#8220;<em>Financial Instruments - Credit Losses</em> (Topic 326).&#8221; The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. This ASU is effective for financial statements issued for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating this guidance to determine the impact it may have on its financial statements. </p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">In 2015, the FASB issued ASU No. 2015-17, &#8220;<em>Income Taxes&#8221;</em> (Topic 740): <em>Balance Sheet Classification of Deferred Taxes</em> , which requires all deferred tax assets and liabilities to be classified as noncurrent in a classified balance sheet. Current US GAAP requires an entity to separate deferred tax assets and liabilities into current and noncurrent amounts in a classified balance sheet. For public entities, ASU 2015-17 is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For all other entities, ASU 2015-17 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018, and may be applied either prospectively or retrospectively, with early application permitted for financial statements that have not been previously issued. The Company has not yet determined the effect of the adoption of this standard on the Company&#x2019;s financial position and results of operations.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>NOTE 3 &#8211; PROPERTY, PLANT AND EQUIPMENT</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>&nbsp;</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The amount capitalized include direct costs and incidental costs incurred in developing the software purchased from the third party.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The following table presents details of our property, plant and equipment costs as of June 30, 2019 and September 30, 2018:</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <table style="width: 100%; border-collapse: collapse; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="white-space: nowrap; padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center;" colspan="2"> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>Balance at</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>September 30, 2018</strong></p> </td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center;" colspan="2"> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>Additions through</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>acquisition of </strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>subsidiaries</strong></p> </td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="font-weight: bold; padding-bottom: 1pt;">&nbsp;</td> <td style="white-space: nowrap; border-bottom: black 1pt solid; font-weight: bold; text-align: center;" colspan="2">Amortization</td> <td style="font-weight: bold; padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center;" colspan="2"> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>Balance at</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>June 30, 2019</strong></p> </td> <td style="padding-bottom: 1pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="white-space: nowrap;">&nbsp;</td> <td>&nbsp;</td> <td style="white-space: nowrap;" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="white-space: nowrap;" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="white-space: nowrap;" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="white-space: nowrap;" colspan="2">&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 40%; padding-bottom: 2.5pt;">Property, plant and equipment, net</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 2.5pt double black;">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right;">159,146</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 2.5pt double black;">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right;">712,027</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 2.5pt double black;">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right;">(111,836</td> <td style="width: 1%; padding-bottom: 2.5pt;">)</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 2.5pt double black;">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right;">759,337</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> </tr> </table> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">Property, plant and equipment costs are being amortized on a straight-line basis over their estimated lives.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The future amortization expense of property, plant and equipment costs as of June 30, 2019 are to be recorded in accordance with their estimated useful lives.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>NOTE 4 &#8211; ACCOUNTS PAYABLE AND ACCRUED EXPENSES</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">Accounts payable at June 30, 2019 and September 30, 2018 totaled $163,748 and $69,805, respectively. While the accrued expenses at June 30, 2019 and September 30, 2018 totaled $738,417 and 38,499, respectively.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong>NOTE 5 &#8211; PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS</strong></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">The Company has paid $1,720 previously advanced from a director for its working capital (see NOTE 6).</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">The Company was granted short term borrowings from financial institutions for its working capital needs. The short term borrowings received is interest bearing as summarized below:</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong>Balance</strong></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong>June 30, 2019</strong></p> </td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center"> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong>Balance</strong></p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px"><strong>September 30,</strong><br /><strong>2018</strong></p> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">&#160;</td> <td style="font-weight: bold">&#160;</td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold">&#160;</td> <td style="font-weight: bold">&#160;</td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">(Restated)</td> <td style="font-weight: bold">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff"> <td style="width: 70%">Short term borrowings</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">381,165</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">40,000</td> <td style="width: 1%">&#160;</td> </tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt">Commercial bills</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">280,360</td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff"> <td style="padding-bottom: 2.5pt">Total</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.5pt double">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">661,525</td> <td style="border-bottom: black 2pt double; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2pt double; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.5pt double">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">40,000</td> <td style="padding-bottom: 2.5pt">&#160;</td> </tr> </table> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">On February 15, 2019, the Company executed a convertible promissory note with Power Up Lending Group LTD (the &#8220;Power Up&#8221;), an unrelated-party, the sum of</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">$138,888 together with any interest as set forth herein, on February 15, 2020 (the &#8220;Maturity Date&#8221;), and to pay interest on the unpaid principal balance hereof at the rate of eight percent (8%)(the &#8220;Interest Rate&#8221;) per annum from the date hereof (the &#8220;Issue Date&#8221;) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The total consideration received against the Note was $138,888, with the Note bearing $500 as a due diligence fee and $2,500 for legal expenses.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">On March 12, 2019, , the Company executed another convertible promissory note with Power Up Lending Group LTD (the &#8220;Power Up&#8221;), the sum of $128,000 together with any interest as set forth herein, on March 12, 2020 (the &#8220;Maturity Date&#8221;), and to pay interest on the unpaid principal balance hereof at the rate of eight percent (8%)(the &#8220;Interest Rate&#8221;) per annum from the date hereof (the &#8220;Issue Date&#8221;) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The total consideration received against the Note was $128,000, with the Note bearing $500 as a due diligence fee and</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">$2,500 for legal expenses.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">On March 12, 2019, the Company executed a convertible promissory note with Labrys Fund, LP (the &#8220;Labrys&#8221;), an unrelated-party, a sum of up to $850,000, bearing an interest rate of 12%, per annum from the date hereof (the &#8220;Issue Date&#8221;) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise as provided herein. The maturity date of each tranche funded under this convertible promissory note shall be six (6) months from the funding date of the respective tranche (each a &#8220;Maturity Date&#8221;). The consideration to the Company for this Note is up to $765,000.00 (the &#8220;Consideration&#8221;) and carries a prorated original issue discount of up to $85,000.00 (the &#8220;OID&#8221;) Total consideration received of the first tranche was $126,000, including $3,000 for legal expenses. At the closing of the First Tranche, the outstanding principal amount under this Note shall be $140,000.00, consisting of the First Tranche plus the prorated portion of the OID. In connection with the funding of the First Tranche of the Note, the Company shall issue to Labrys, as a commitment fee, 92,105 shares of its common stock (the &#8220;First Returnable Shares&#8221;), as further provided in the Note, as well as to issue 15,000 shares (the &#8220;Commitment Shares&#8221;) to Labrys on the Closing Date, as a commitment fee.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">On March 19, 2019, the Company executed a convertible promissory note with Auctus Fund, LLC (the &#8220;Auctus&#8221;), an unrelated-party, a sum of $350,000, together with any interest as set forth herein, on December 19, 2019 (the &#8220;Maturity Date&#8221;), and to pay interest on the unpaid principal balance hereof at the rate of twelve percent (12%) (the &#8220;Interest Rate&#8221;) per annum from the date hereof (the &#8220;Issue Date&#8221;) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. ). The total consideration received against the Note was $350,000, with the Note bearing $35,000 as a due diligence fee and $2,750 for legal expenses. In connection with the funding of the Note, the Company shall issue to Auctus on the Closing Date, as a commitment fee,</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">35,000 shares of the Company&#x2019;s common stock (the &#8220;Commitment Shares&#8221;), as well as 175,000 shares of its common stock (the &#8220;Returnable Shares&#8221;, as further provided in the Note). The Returnable Shares and Commitment Shares shall be deemed earned in full as of the Closing Date.</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">&#160;</p> <p style="font-stretch: normal; font: 10pt/normal Times New Roman, Times, serif; margin: 0pt 0px">The Company&#8217;s subsidiary, GGLG Properties Pty Ltd executed an $280,360 (AUD$400,000) commercial bill with National Australia Bank Limited, with a fixed interest rate for each rollover period.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>NOTE 6 &#8211; RELATED PARTY TRANSACTIONS</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>&nbsp;</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">During the financial period under review, the Company paid an amount of $1,720 to the directors of the Company as of June 30, 2019, whilst received an advances of $11,210 from directors for its working capital needs as of September 30, 2018, respectively. Funds advanced to the Company by the director are non- interest bearing, unsecured and due on demand.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The Company has received advances for its working capital needs from an affiliate in which the Company&#x2019;s Chief Executive Officer holds the position of director in such entity (see NOTE 5).</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">As for the sales to related parties, the amounts are disclosed on Condensed Statements Of Operations (PAGE 2).</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>NOTE 7 &#8211; COMMITMENTS AND CONTINGENCIES </strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>&nbsp;</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>Litigation Costs and Contingencies</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>&nbsp;</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Other than as set forth below, management is currently not aware of any such legal proceedings or claims that could have, individually or in the aggregate, a material adverse effect on our business, financial condition, or operating results.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">In the normal course of business, the Company incurs costs to hire and retain external legal counsel to advise it on regulatory, litigation and other matters. The Company expenses these costs as the related services are received. If a loss is considered probable and the amount can be reasonable estimated, the Company recognizes an expense for the estimated loss.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">Contingent liabilities that are probable to arise from the recent legal related to the company&#x2019;s subsidiary Prema Life Pty Ltd, the details are disclosed on Part II, Item 1. Legal Proceedings (<font style="background-color: yellow;">Page</font><font style="font-size: 10pt;">&nbsp;</font> <font style="background-color: yellow;">16</font>).</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>NOTE 8: STOCKHOLDERS&#x2019; DEFICIT</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The Company&#x2019;s capitalization at June 30, 2019 was 500,000,000 authorized common shares with a par value of $0.001 per share.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>Common Stock</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">On December 3, 2018, the Company agreed to purchase 51% of the issued and outstanding capital stock of Prema Life Pty Ltd and 60% of the issued and outstanding capital stock of GGLG Properties PTY Ltd, collectively in exchange for 304,500 shares of the Company&#x2019;s common stock valued at $1,218,000 based on the fair value of the common stock on the closing date. On December 28, 2018, the parties mutually agreed to extend the closing of the purchase transaction on January 1, 2019. The Company issued 304,500 shares of its common stock on December 3, 2018 in good faith for consummating the purchase. The Company has recorded the fair value of the common stock issued as stock subscriptions receivable at December 31, 2018.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">On March 12, 2019, the Company executed a convertible promissory note with Labrys Fund, LP (the &#8220;Labrys&#8221;). In connection with the funding of the First Tranche of the Note, the Company shall issue to Labrys, as a commitment fee, 92,105 shares of its common stock (the &#8220;First Returnable Shares&#8221;), as further provided in the Note, as well as to issue 15,000 shares (the &#8220;Commitment Shares&#8221;) to Labrys on the Closing Date, as a commitment fee.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">On March 19, 2019, the Company executed a convertible promissory note with Auctus Fund, LLC (the &#8220;Auctus&#8221;). In connection with the funding of the Note, the Company shall issue to Auctus on the Closing Date, as a commitment fee, 35,000 shares of the Company&#x2019;s common stock (the &#8220;Commitment Shares&#8221;), as well as 175,000 shares of its common stock (the &#8220;Returnable Shares&#8221;, as further provided in the Note). The Returnable Shares and Commitment Shares shall be deemed earned in full as of the Closing Date.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">On March 20, 2019, the company executed a convertible promissory note with EMA Financial, LLC (the &#8220;EMA&#8221;). In connection with the funding of the First Tranche of the Note, the Company shall issue to EMA, 15,000 shares of restricted common stock as a commitment fee the &#8220;Commitment Shares&#8221;), as well as 86,800 shares of restricted common stock (the &#8220;Returnable Shares&#8221;), as further provided in the Note). In the event the Company fails to redeem the tranche by its maturity date the Returnable Shares shall not be returned to the Company</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">As a result of all common stock issuances, the Company had 162,278,405 shares and 161,555,000 shares of common stock issued and outstanding at June 30, 2019 and September 30, 2018, respectively.</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong><u>Use of Estimates</u></strong></p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related party. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company&#x2019;s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong><u>Cash and Cash Equivalents</u></strong></p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. Company had a cash balance of $868,537 at June 30, 2019 and $439,846 at September 30, 2018, respectively.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong><u>Property, Plant and Equipment</u></strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">Property, plant and equipment costs include direct costs incurred for purchase of fixed assets and payments made to independent suppliers. The Company accounts for property, plant and equipment costs in accordance with the FASB guidance for the costs of property, plant and equipment to be sold, leased, or otherwise marketed (&#8220;ASC Subtopic 985-20&#8221;). As for the computer software costs, they are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Computer software costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to computer software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered 'research and development&#x2019; that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">Commencing upon product release, capitalized computer software costs are amortized on the straight-line method over a thirty-six months period. The Company evaluates the future recoverability of capitalized computer software costs on an annual basis.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong><u>Concentration of Risk</u></strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company does not have the cash balances in excess of Federal Deposit Insurance Corporation limit at June 30, 2019 and September 30, 2018, respectively.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong><u>Income Taxes</u></strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, &#8220;<em>Income Taxes&#8221;</em> . The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The Company follows the provisions of ASC 740-10, &#8220;<em>Accounting for Uncertain Income Tax Positions</em>&#8221; When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying condensed balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong><u>Earnings (Loss) Per Common Share</u></strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The Company computes net earnings (loss) per share in accordance with ASC 260, &#8220;<em>Earnings per Share&#8221;</em> . ASC 260 requires presentation of both basic and diluted net earnings per share (&#8220;EPS&#8221;) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. At June 30, 2019 and September 30, 2018, there were no convertible notes, options or warrants available for conversion that if exercised, may dilute future earnings per share.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong><u>Fair value of Financial Instruments and Fair Value Measurements</u></strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">ASC 820, &#8220;<em>Fair Value Measurements and Disclosures&#8221;,</em> requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument&#x2019;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><em>Level 1</em></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><em>Level 2</em></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><em>Level 3</em></p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><em>&nbsp;</em></p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The Company&#x2019;s financial instruments consist principally of cash, accounts payable, accrued expenses and payable to an affiliate. Pursuant to ASC 820, &#8220;<em>Fair Value Measurements and Disclosures&#8221;</em> and ASC 825, &#8220;<em>Financial Instruments&#8221;</em>, the fair value of our cash equivalents is determined based on &#8220;Level 1&#8221; inputs, which consist of quoted prices in active markets for identical assets. The Company believes that the recorded values of all the other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The following table presents assets and liabilities that were measured and recognized at fair value as of March 31, 2019 on a recurring basis:</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <table style="width: 100%; border-collapse: collapse; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="width: 55%; border-bottom: black 1pt solid; text-align: center;">Description</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center;">Level 1</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center;">Level 2</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center;">Level 3</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 1pt;">None</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> </tr> </table> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:<!-- Field: Page; Sequence: 10 --> <!-- Field: /Page --></p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <table style="width: 100%; border-collapse: collapse; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="width: 55%; padding-bottom: 1pt; text-align: center;">Description</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1pt solid black;">&nbsp;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center;">Level 1</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1pt solid black;">&nbsp;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center;">Level 2</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1pt solid black;">&nbsp;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center;">Level 3</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 1pt;">None</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> </tr> </table> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong><u>Recent Accounting Pronouncements</u></strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">In June 2016, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, &#8220;<em>Financial Instruments - Credit Losses</em> (Topic 326).&#8221; The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. This ASU is effective for financial statements issued for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating this guidance to determine the impact it may have on its financial statements.</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">In 2015, the FASB issued ASU No. 2015-17, &#8220;<em>Income Taxes&#8221;</em> (Topic 740): <em>Balance Sheet Classification of Deferred Taxes</em> , which requires all deferred tax assets and liabilities to be classified as noncurrent in a classified balance sheet. Current US GAAP requires an entity to separate deferred tax assets and liabilities into current and noncurrent amounts in a classified balance sheet. For public entities, ASU 2015-17 is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For all other entities, ASU 2015-17 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018, and may be applied either prospectively or retrospectively, with early application permitted for financial statements that have not been previously issued. The Company has not yet determined the effect of the adoption of this standard on the Company&#x2019;s financial position and results of operations.</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The following table presents assets and liabilities that were measured and recognized at fair value as of March 31, 2019 on a recurring basis:</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <table style="width: 100%; border-collapse: collapse; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="width: 55%; border-bottom: black 1pt solid; text-align: center;">Description</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center;">Level 1</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center;">Level 2</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center;">Level 3</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 1pt;">None</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> </tr> </table> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:</p> <p style="text-align: justify; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <table style="width: 100%; border-collapse: collapse; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="width: 55%; padding-bottom: 1pt; text-align: center;">Description</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1pt solid black;">&nbsp;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center;">Level 1</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1pt solid black;">&nbsp;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center;">Level 2</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1pt solid black;">&nbsp;</td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center;">Level 3</td> <td style="width: 1%; padding-bottom: 1pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 1pt;">None</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> </tr> </table> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The following table presents details of our property, plant and equipment costs as of June 30, 2019 and September 30, 2018:</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <table style="width: 100%; border-collapse: collapse; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="white-space: nowrap; padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center;" colspan="2"> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>Balance at</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>September 30, 2018</strong></p> </td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center;" colspan="2"> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>Additions through</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>acquisition of </strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>subsidiaries</strong></p> </td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="font-weight: bold; padding-bottom: 1pt;">&nbsp;</td> <td style="white-space: nowrap; border-bottom: black 1pt solid; font-weight: bold; text-align: center;" colspan="2">Amortization</td> <td style="font-weight: bold; padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center;" colspan="2"> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>Balance at</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>June 30, 2019</strong></p> </td> <td style="padding-bottom: 1pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="white-space: nowrap;">&nbsp;</td> <td>&nbsp;</td> <td style="white-space: nowrap;" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="white-space: nowrap;" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="white-space: nowrap;" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="white-space: nowrap;" colspan="2">&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 40%; padding-bottom: 2.5pt;">Property, plant and equipment, net</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 2.5pt double black;">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right;">159,146</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 2.5pt double black;">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right;">712,027</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 2.5pt double black;">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right;">(111,836</td> <td style="width: 1%; padding-bottom: 2.5pt;">)</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 2.5pt double black;">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right;">759,337</td> <td style="width: 1%; padding-bottom: 2.5pt;">&nbsp;</td> </tr> </table> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">The Company was granted short term borrowings from financial institutions for its working capital needs. The short term borrowings received is interest bearing as summarized below:</p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;">&nbsp;</p> <table style="width: 100%; border-collapse: collapse; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="white-space: nowrap; padding-bottom: 1pt;">&nbsp;</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="white-space: nowrap; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center;" colspan="2"> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>Balance</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>June 30, 2019</strong></p> </td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt;">&nbsp;</td> <td style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center;" colspan="2"> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>Balance</strong></p> <p style=" font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'Times New Roman', Times, serif; margin: 0pt 0px;"><strong>September 30,</strong><br/><strong>2018</strong></p> </td> <td style="padding-bottom: 1pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="white-space: nowrap;">&nbsp;</td> <td style="font-weight: bold;">&nbsp;</td> <td style="white-space: nowrap; font-weight: bold; text-align: center;" colspan="2">(Unaudited)</td> <td style="font-weight: bold;">&nbsp;</td> <td style="font-weight: bold;">&nbsp;</td> <td style="white-space: nowrap; font-weight: bold; text-align: center;" colspan="2">(Restated)</td> <td style="font-weight: bold;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 70%;">Short term borrowings</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">$</td> <td style="width: 12%; text-align: right;">381,165</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">$</td> <td style="width: 12%; text-align: right;">40,000</td> <td style="width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="padding-bottom: 1pt;">Commercial bills</td> <td style="padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">280,360</td> <td style="border-bottom: 1pt solid black; padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt;">&nbsp;</td> <td style="border-bottom: 1pt solid black;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 2.5pt;">Total</td> <td style="padding-bottom: 2.5pt;">&nbsp;</td> <td style="border-bottom: 2.5pt double black;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">661,525</td> <td style="border-bottom: 2pt double black; padding-bottom: 2.5pt;">&nbsp;</td> <td style="border-bottom: black 2pt double; padding-bottom: 2.5pt;">&nbsp;</td> <td style="border-bottom: 2.5pt double black;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">40,000</td> <td style="padding-bottom: 2.5pt;">&nbsp;</td> </tr> </table> 38499 738417 40000 661525 1218000 304500 0.51 0.60 86800 15000 175000 35000 15000 92105 92105 175000 175000 30:1 forward stock split 0.60 0.51 304500 304500 304500 138888 128000 850000 350000 2020-02-15 2020-03-12 2019-12-19 P6M 0.08 0.08 0.12 0.12 138888 128000 350000 765000 126000 500 500 35000 2500 2500 2750 3000 85000 140000 true true false P36M 159146 759337 712027 -111836 1720 11210 901854 771943 506663 1037266 145240 109626 43675 117726 35845 12130 12300 58165 194474 123892 450688 861375 162186300 11418 -1720 105000 526295 NV Yes 280360 280360 400000 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><u>Revenue Recognition and Concentrations</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We generate revenue from licensing and other software services from our web-based software to distributors and retailers of nutritional supplements in the healthcare industry. We recognize licensing fees and other software services as revenue over the period of the contract at the time that the computer software is delivered and accepted by the customer, the selling price is fixed, and collection is reasonably assured, provided no significant obligations remain. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Deferred revenues represent billings or cash received in excess of revenue recognizable on service agreements that are not accounted for as revenues.&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Through our subsidiaries, Natural Tech R&#38;D Sdn Bhd and Prema Life Pty Ltd, we generate revenue from distributing health supplements, naturopathic medicines and other health food products. Prema Life Pty Ltd also manufactured goods and packaging for contract clients.</p> false 1720 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 9 &#8211; SUBSEQUENT EVENTS </b>&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management has evaluated subsequent events through August 14&#160;, 2019, the date the financial statements were available to be issued, noting no items that would impact the accounting for events or transactions in the current period except for:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif">&#8226;</td> <td style="font: 10pt Times New Roman, Times, Serif">On July 2, 2019 and August 2, 2019, the Company settled the remaining balances of the convertible promissory note in full for total $140,000 to Labrys Fund, LP, the 92,105 returnable shares was returned to company on August 7, 2019;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif">&#8226;</td> <td style="font: 10pt Times New Roman, Times, Serif">On July 3, 2019 and July 29, 2019 the Company settled the remaining balances of the convertible promissory note in full for total $350,000 to Auctus Fund, LLC. The arrangement with Auctus to return the returnable shares of 175,000 is in progress; and</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif">&#8226;</td> <td style="font: 10pt Times New Roman, Times, Serif">On July 5, 2019 and July 31, 2019, the Company settled the remaining balances of the convertible promissory note in full for total $266,000 to Power Up Lending Group LTD.</td></tr> </table> 140000 140000 350000 350000 266000 266000 EX-101.SCH 7 nhel-20190630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - PROPERTY, PLANT AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - STOCKHOLDERS' DEFICIT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 nhel-20190630_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 nhel-20190630_def.xml XBRL DEFINITION FILE EX-101.LAB 10 nhel-20190630_lab.xml XBRL LABEL FILE Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Related Party [Axis] Prema Life Pty Ltd [Member] GGLG Properties PTY Ltd [Member] Debt Instrument [Axis] Convertible Promissory Note [Member] EMA Financial, LLC [Member] Vesting [Axis] First Tranche [Member] Class of Stock [Axis] First Returnable Shares [Member] Award Type [Axis] Restricted Stock [Member] Commitment Shares [Member] Auctus Fund, LLC [Member] Labrys Fund, LP [Member] Ownership [Axis] GGLG Properties Pty Ltd [Member] Prema Life Pty Ltd And GGLG Properties Pty Ltd [Member] Legal Entity [Axis] Power Up Lending Group LTD [Member] National Australia Bank Limited [Member] Currency [Axis] Australia, Dollars Subsequent Event Type [Axis] Subsequent Event [Member] Returnable Shares [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Entity File Number Title of 12(b) Security Trading Symbol Entity Incorporation, State or Country Code Entity Interactive Data Current Current Fiscal Year End Date Entity Reporting Status Current Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Filer Category Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Account receivables - third parties Account receivables - related parties Other receivables and deposits Inventories Tax assets Total Current Assets Property, plant and equipment, net Goodwill Total Non-Current Assets Total Assets LIABILITIES AND EQUITY Current Liabilities Accounts payable Accrued expense Payable to affiliate Deferred revenue - third parties Deferred revenue - related parties Short term borrowings Advances from directors Commercial bill Total Current Liabilities Deferred tax liabilities - Non-Current liabilities Total Liabilities Equity Common Stock, $0.001 par value, 500,000,000 shares authorized, 162,177,000 shares and 161,555,000 shares issued and outstanding at March 31, 2019 and September 30, 2018, respectively Additional Paid in Capital Accumulated deficit Foreign currency translation reserve Merger reserve Total equity attributable to owners of the Company Non-controlling interests Total Equity Total Liabilities and Equity Common stock, par value (in dollars per share) Common stock, authorized Common stock, issued Common stock, outstanding Income Statement [Abstract] Revenues - related parties Revenues - third parties Total Revenues Cost of Goods Sold Gross Profit Operating Expenses: Consulting fees Legal and filing fees Stock compensation Other general and administrative Total Operating and Administrative Expenses Profit/(Loss) from Operations Other income Finance costs Profit/(Loss) Before Provision For Income Tax Provision for income tax Net Profit/(Loss) Other comprehensive (expenses)/income Foreign currency translation differences Total comprehensive income/(expense) for the period Loss attributable to: Owners of the Company Non-controlling interests Income /(Loss) for the period Total comprehensive expense attributable to: Owners of the Company Non-controlling interests Total comprehensive income/(expense) for the period Earnings per share (in dollars per share) Weighted Average Number of Shares Outstanding - Basic and Diluted (in shares) Statement of Cash Flows [Abstract] Cash Flows from Operating Activities: Net Loss Adjustment to reconcile net loss to net cash provided by (used in) operating activities Depreciation and Amortization of plant and equipment Common stock issued to consultants for services Stock compensation expense upon grant of stock options Changes in operating assets and liabilities Account receivables Account payables Directors Inventories Net Cash Flows (Used in)/Provided by Operating Activities Cash Flows from Investing Activities Purchase of plant & equipment Acquisition of subsidiaries, net of cash and cash equivalents Cash inflows from merger and acquisition, net Net Cash Flows (Used in)/Provided by Investing Activities Cash Flows from Financing Activity Drawdowns of borrowings, net Proceeds from issuance of shares Net Cash Flows Provided by Financing Activity Net Increase in Cash and Cash Equivalents Cash and Cash Equivalents, Beginning of the Period Cash and Cash Equivalents, End of the Period Supplemental Disclosures of Cash Flow Information: Cash paid for Income Taxes Cash paid for Interest Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Property, Plant and Equipment [Abstract] PROPERTY, PLANT AND EQUIPMENT Payables and Accruals [Abstract] ACCOUNTS PAYABLE AND ACCRUED EXPENSES Payable To Affiliates And Drawdowns Of Short Term Borrowings PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] STOCKHOLDERS' DEFICIT Subsequent Events [Abstract] SUBSEQUENT EVENTS Use of Estimates Cash and Cash Equivalents Property, Plant and Equipment Revenue Recognition and Concentrations Concentration of Risk Income Taxes Earnings (Loss) Per Common Share Fair value of Financial Instruments and Fair Value Measurements Recent Accounting Pronouncements Schedule of assets and liabilities measured and recognized at fair value Schedule of property, plant and equipment costs Schedule of granted short term borrowings from financial institutions Statement [Table] Statement [Line Items] Business Acquisition [Axis] Description of forward stock split Increased authorized share capital Net cash used in operating activities Working capital deficit Business combination considerations Percentage of ownership Number of common shares conversion (in shares) Number of shares issued (in shares) Fair Value Hierarchy and NAV [Axis] Assets and liabilities at fair value Cash balance Useful life of computer software Balance at beginning Additions through acquisition of subsidiaries Amortization Balance at ending Accrued expenses Commercial bills Total Debt instrument Debt instrument maturity date Debt instrument maturity terms Debt instrument interest rate Proceeds from debt instrument Due diligence fee Legal expenses Original issue discount Debt instrument principal amount Number of shares issued as commitment fee (in shares) Payments for Advance to Affiliate Due to director Advance from director Previously common stock, authorized Value of shares issued Number of shares issued (in shares) Purchase price (in dollars per share) Cash proceeds from issuance of shares Number of new shares issued, value Value of shares issued during the period Common stock subscriptions, value Ownership percentage Common stock capital reserve for future issuance Number for shares purchased Term Exercise price options to purchase Expiration date Subsequent Event [Table] Subsequent Event [Line Items] Principal amount Amount of assets and liabilities at fair value. Information pertaining to Auctus Fund LLC. Amount refers to cash inflows from merger and acquisition net. Information pertainig to commitment shares. The maximum number of common shares previously permitted to be issued by an entity's charter and bylaws. Expenses related to consulting fees. Information pertaining to convertible promissory note. The increase (decrease) during the reporting period in directors expenses. Amount refers to due diligence fee. Information pertaining to EMA Financial LLC. Expenses related to filing fees. Information pertaining to first returnable shares. The amount refers to foreign currency translation reserve. Information pertaining to GGLG Properties Pty Ltd. It represents gglg properties member. Information pertaining to Labrys Fund LP. The amount refers to merger reserve. Represents ownership percentage. The entire disclosure for payable to affiliate disclosure. Information pertaining to Power Up Lending Group LTD. It represents premal life member. It represents premal life member. It represents premal life member. Amount of revenue related to nonrelated parties recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Amount of revenue related to related parties recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Number of new stock issued during the period. Number of new stock issued during the period. It represent of working capital deficit. Represents the information pertaining to national australia bank limited. Information pertaining to returnable shares. Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Stockholders' Equity Attributable to Parent Liabilities and Equity Revenues Cost of Revenue Gross Profit Consulting fees Legal and filing fees Share-based Payment Arrangement, Expense Other Selling, General and Administrative Expense Operating Expenses Operating Income (Loss) Finance Lease, Interest Expense Nonoperating Income (Expense) Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Payments to Acquire Property, Plant, and Equipment Payments to Acquire Projects Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Period Increase (Decrease) Property, Plant and Equipment, Gross Due to Affiliate Stock Issued During Period, Shares, Issued for Services EX-101.PRE 11 nhel-20190630_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.19.2
Document and Entity Information - shares
 9 Months Ended
Jun. 30, 2019
Aug. 12, 2019
Document And Entity Information    
Entity Registrant Name NATURAL HEALTH FARM HOLDINGS INC  
Entity Central Index Key 0001621697  
Document Type 10-Q  
Document Period End Date Jun. 30, 2019  
Amendment Flag false  
Entity File Number 000-1621697  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol NHEL  
Entity Incorporation, State or Country Code NV  
Entity Interactive Data Current Yes  
Current Fiscal Year End Date --09-30  
Entity Reporting Status Current Yes  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Filer Category Non-accelerated Filer  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   162,186,300
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2019  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
Jun. 30, 2019
Sep. 30, 2018
Current Assets    
Cash and cash equivalents $ 868,537 $ 439,846
Account receivables - third parties 454,638 105,018
Account receivables - related parties 226,548
Other receivables and deposits 712,165 95,569
Inventories 578,732
Tax assets 5,714 5,463
Total Current Assets 2,619,786 872,444
Property, plant and equipment, net 795,337 159,146
Goodwill 1,118,843
Total Non-Current Assets 1,914,180 159,146
Total Assets 4,533,966 1,031,590
Current Liabilities    
Accounts payable 163,748 69,805
Accrued expense 738,417 38,499
Payable to affiliate 644,794 311,337
Deferred revenue - third parties 40,369 48,694
Deferred revenue - related parties 30,416 57,341
Short term borrowings 381,165 40,000
Advances from directors 9,490 11,210
Commercial bill 280,360  
Total Current Liabilities 2,288,759 576,886
Deferred tax liabilities - Non-Current liabilities 8,119 6,817
Total Liabilities 2,296,878 583,703
Equity    
Common Stock, $0.001 par value, 500,000,000 shares authorized, 162,177,000 shares and 161,555,000 shares issued and outstanding at March 31, 2019 and September 30, 2018, respectively 162,279 161,555
Additional Paid in Capital 2,562,782 857,783
Accumulated deficit (1,022,658) (1,071,993)
Foreign currency translation reserve (24,596) (16,758)
Merger reserve 517,300 517,300
Total equity attributable to owners of the Company 2,195,107 447,887
Non-controlling interests 41,981
Total Equity 2,237,088 447,887
Total Liabilities and Equity $ 4,533,966 $ 1,031,590
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Jun. 30, 2019
Sep. 30, 2018
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, authorized 500,000,000 500,000,000
Common stock, issued 162,177,000 161,555,000
Common stock, outstanding 162,177,000 161,555,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Income Statement [Abstract]        
Revenues - related parties $ 656,137 $ 264,692 $ 970,676 $ 480,350
Revenues - third parties 150,250 9,782 642,752 14,647
Total Revenues 806,387 274,474 1,613,428 494,997
Cost of Goods Sold (256,206) (121,513) (596,148) (242,613)
Gross Profit 550,181 152,961 1,017,280 252,384
Operating Expenses:        
Consulting fees (43,675) (109,626) (117,726) (145,240)
Legal and filing fees (12,300) (12,130) (58,165) (35,845)
Stock compensation (526,295) (526,295)
Other general and administrative (450,688) (123,892) (861,375) (194,474)
Total Operating and Administrative Expenses (506,663) (771,943) (1,037,266) (901,854)
Profit/(Loss) from Operations 43,518 (618,982) (19,986) (649,470)
Other income 74,271 446 77,764 1,052
Finance costs (2,803) (11,036)
Profit/(Loss) Before Provision For Income Tax 114,986 (618,536) 46,742 (648,418)
Provision for income tax
Net Profit/(Loss) 114,986 (618,536) 46,742 (648,418)
Other comprehensive (expenses)/income        
Foreign currency translation differences (16,710) (37,222) (1,880) (2,261)
Total comprehensive income/(expense) for the period 98,276 (655,758) 44,862 (650,679)
Loss attributable to:        
Owners of the Company 74,760 (655,758) 49,335 (648,418)
Non-controlling interests 40,226 (2,593)
Income /(Loss) for the period 114,986 (655,758) 46,742 (648,418)
Total comprehensive expense attributable to:        
Owners of the Company 52,449 (655,758) 41,498 (650,679)
Non-controlling interests 45,827 3,364
Total comprehensive income/(expense) for the period $ 98,276 $ (655,758) $ 44,862 $ (650,679)
Earnings per share (in dollars per share)
Weighted Average Number of Shares Outstanding - Basic and Diluted (in shares) 162,278,405 156,201,374 162,278,405 150,151,000
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash Flows from Operating Activities:    
Net Loss $ 46,742 $ (648,418)
Adjustment to reconcile net loss to net cash provided by (used in) operating activities    
Depreciation and Amortization of plant and equipment 111,836 7,582
Common stock issued to consultants for services 105,000
Stock compensation expense upon grant of stock options   526,295
Changes in operating assets and liabilities    
Account receivables (566,261) (411,104)
Account payables (69,540) 457,681
Directors (1,720) 11,418
Inventories (160,838)
Net Cash Flows (Used in)/Provided by Operating Activities (639,781) 48,454
Cash Flows from Investing Activities    
Purchase of plant & equipment (61,808)
Acquisition of subsidiaries, net of cash and cash equivalents (1,196,967) (55,611)
Cash inflows from merger and acquisition, net 277,180
Net Cash Flows (Used in)/Provided by Investing Activities (1,258,775) 221,569
Cash Flows from Financing Activity    
Drawdowns of borrowings, net 621,525
Proceeds from issuance of shares 1,705,722 40,724
Net Cash Flows Provided by Financing Activity 2,327,247 40,724
Net Increase in Cash and Cash Equivalents 428,691 310,747
Cash and Cash Equivalents, Beginning of the Period 439,846  
Cash and Cash Equivalents, End of the Period 868,537 310,747
Supplemental Disclosures of Cash Flow Information:    
Cash paid for Income Taxes
Cash paid for Interest
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.2
NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN
 9 Months Ended
Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN

NOTE 1 – NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN

 

Natural Health Farm Holdings Inc. (the “Company”, “We”, “Its”, and “NHEL”) was incorporated under the laws of the State of Nevada on July 10, 2014 (Inception date). The Company has developed web-based business and launched itself into the healthcare industry. The Company has plans to provide through its subsidiaries, retail nutritional supplements, organic foods, personal care, and other health care products. The company has positioned itself to be a fully integrated nutraceutical biotechnology company offering products and related services through healthcare practitioners and direct-to-consumers. The company now owns a research & development laboratory in Malaysia, franchisee management services company and an Australia manufacturing facility producing practitioner only naturopathic and homeopathic medicines.

 

On November 30, 2016, the Company filed a certificate of amendment to its articles of incorporation with the Nevada Secretary of State to change its name from Amber Group Inc. to Natural Health Farm Holdings Inc. and effectuated a 30:1 forward stock split of its common stock and increased its authorized share capital to 500,000,000 (Five Hundred Million). This amendment was unanimously approved by the Company’s board of directors on November 29, 2016, and with the stockholders holding a majority of the Company’s voting power.

 

On March 16, 2017, Financial Industry Regulatory Authority (FINRA) approved the corporate name change to Natural Health Farm Holdings Inc., approved the increase in the Company’s authorized shares of common stock to 500,000,000 shares, and approved 30:1 forward stock split effective March 17, 2017.  The new trading symbol for our common stock is “NHEL”.

 

On January 31, 2018, the company acquired the total outstanding share of NHF International Limited at at nominal value. Upon the completion of the acquisition, its subsidiaries, both Natural Tech R&D Sdn Bhd and NHF Management & Business Sdn Bhd become wholly subsidiaries of the Group. As this transaction is business combination under common control, as deliberated and determined by Directors of the Company, difference between purchase considerations and net tangible assets acquired is recorded in merger reserves which amounted to $517,300. Natural Tech R&D Sdn Bhd, a BioNexus Status Company in Malaysia, specializes in research and development, cultivation, extraction and commercialization of nutraceuticals based on medicinal fungi and NHF Management & Business Sdn Bhd, providing franchisee management services and consultation, such as point-of-sales system, resources, branding and marketing.

 

On December 3, 2018, the Company agreed to purchase 51% of the issued and outstanding capital stock of Prema Life Pty Ltd and 60% of the issued and outstanding capital stock of GGLG Properties Pty Ltd, collectively in exchange for 304,500 shares of the Company’s common stock. On December 28, 2018, the parties mutually agreed to extend the closing date of the purchase transaction on January 1, 2019. The Company issued 304,500 shares of its common stock on December 3, 2018 in good faith for consummating the purchase.

 

The corporate structure is depicted below:

 

Basis of Presentation

 

The accompanying interim condensed financial statements are unaudited, but in the opinion of management of the Company, contain all adjustments, which include normal recurring adjustments necessary to present fairly the financial position at June 30, 2019, and the results of operations for three months and six months ended June 30, 2019, and cash flows for the six months ended June 30, 2019 and 2018. The balance sheet as of September 30, 2018 is derived from the Company’s audited financial statements.

 

Certain information and footnote disclosures normally included in financial statements that have been prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission, although management of the Company believes that the disclosures contained in these interim condensed financial statements are adequate to make the information presented therein not misleading. For further information, refer to the financial statements and the notes thereto contained in the Company’s September 30, 2018 Annual Report filed with the Securities and Exchange Commission on Form 10-K on December 28, 2018.

 

Going Concern

   

The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has generated small revenues and has sustained cumulative operating losses since July 10, 2014 (Inception Date) to date and allow it to continue as a going concern. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders and affiliates, the ability of the Company to obtain necessary financing to continue operations, and the attainment of profitable operations. The Company recorded a net cash out flows in operating activities of $639,781 and has an accumulated deficit of $1,022,658 as of June 30, 2019.

 

These factors, among others, raise a substantial doubt regarding the Company’s ability to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying consolidated financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 9 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The following summary of significant accounting policies of the Company is presented to assist in the understanding of the Company’s financial statements. The financial statements and notes are the representation of the Company’s management who is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America (“GAAP”) in all material respects and have been consistently applied in preparing the accompanying financial statements.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related party. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. Company had a cash balance of $868,537 at June 30, 2019 and $439,846 at September 30, 2018, respectively.

 

Property, Plant and Equipment

 

Property, plant and equipment costs include direct costs incurred for purchase of fixed assets and payments made to independent suppliers. The Company accounts for property, plant and equipment costs in accordance with the FASB guidance for the costs of property, plant and equipment to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). As for the computer software costs, they are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Computer software costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to computer software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered 'research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation.

 

Commencing upon product release, capitalized computer software costs are amortized on the straight-line method over a thirty-six months period. The Company evaluates the future recoverability of capitalized computer software costs on an annual basis.

 

Revenue Recognition and Concentrations

 

We generate revenue from licensing and other software services from our web-based software to distributors and retailers of nutritional supplements in the healthcare industry. We recognize licensing fees and other software services as revenue over the period of the contract at the time that the computer software is delivered and accepted by the customer, the selling price is fixed, and collection is reasonably assured, provided no significant obligations remain. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting.

 

Deferred revenues represent billings or cash received in excess of revenue recognizable on service agreements that are not accounted for as revenues.

 

Through our subsidiaries, Natural Tech R&D Sdn Bhd and Prema Life Pty Ltd, we generate revenue from distributing health supplements, naturopathic medicines and other health food products. Prema Life Pty Ltd also manufactured goods and packaging for contract clients.

 

Concentration of Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company does not have the cash balances in excess of Federal Deposit Insurance Corporation limit at June 30, 2019 and September 30, 2018, respectively.

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes” . The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

The Company follows the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions” When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying condensed balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

 

Earnings (Loss) Per Common Share

 

The Company computes net earnings (loss) per share in accordance with ASC 260, “Earnings per Share” . ASC 260 requires presentation of both basic and diluted net earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. At June 30, 2019 and September 30, 2018, there were no convertible notes, options or warrants available for conversion that if exercised, may dilute future earnings per share.

 

Fair value of Financial Instruments and Fair Value Measurements

 

ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

 

Level 1

 

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2

 

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

 

Level 3

 

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

The Company’s financial instruments consist principally of cash, accounts payable, accrued expenses and payable to an affiliate. Pursuant to ASC 820, “Fair Value Measurements and Disclosures” and ASC 825, “Financial Instruments”, the fair value of our cash equivalents is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The Company believes that the recorded values of all the other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

 

The following table presents assets and liabilities that were measured and recognized at fair value as of March 31, 2019 on a recurring basis:

 

Description     Level 1       Level 2       Level 3  
None   $ -     $ -     $ -  

 

The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:

 

Description     Level 1       Level 2       Level 3  
None   $ -     $ -     $ -  

 

Recent Accounting Pronouncements

 

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses (Topic 326).” The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. This ASU is effective for financial statements issued for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating this guidance to determine the impact it may have on its financial statements.

 

In 2015, the FASB issued ASU No. 2015-17, “Income Taxes” (Topic 740): Balance Sheet Classification of Deferred Taxes , which requires all deferred tax assets and liabilities to be classified as noncurrent in a classified balance sheet. Current US GAAP requires an entity to separate deferred tax assets and liabilities into current and noncurrent amounts in a classified balance sheet. For public entities, ASU 2015-17 is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For all other entities, ASU 2015-17 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018, and may be applied either prospectively or retrospectively, with early application permitted for financial statements that have not been previously issued. The Company has not yet determined the effect of the adoption of this standard on the Company’s financial position and results of operations.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.2
PROPERTY, PLANT AND EQUIPMENT
 9 Months Ended
Jun. 30, 2019
Property, Plant and Equipment [Abstract]  
PROPERTY, PLANT AND EQUIPMENT

NOTE 3 – PROPERTY, PLANT AND EQUIPMENT

 

The amount capitalized include direct costs and incidental costs incurred in developing the software purchased from the third party.

 

The following table presents details of our property, plant and equipment costs as of June 30, 2019 and September 30, 2018:

 

   

Balance at

September 30, 2018

    

Additions through

acquisition of

subsidiaries

     Amortization    

Balance at

June 30, 2019

  
                         
Property, plant and equipment, net   $ 159,146     $ 712,027     $ (111,836 )   $ 759,337  

 

Property, plant and equipment costs are being amortized on a straight-line basis over their estimated lives.

 

The future amortization expense of property, plant and equipment costs as of June 30, 2019 are to be recorded in accordance with their estimated useful lives.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.2
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
 9 Months Ended
Jun. 30, 2019
Payables and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED EXPENSES

NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable at June 30, 2019 and September 30, 2018 totaled $163,748 and $69,805, respectively. While the accrued expenses at June 30, 2019 and September 30, 2018 totaled $738,417 and 38,499, respectively.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.19.2
PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS
 9 Months Ended
Jun. 30, 2019
Payable To Affiliates And Drawdowns Of Short Term Borrowings  
PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS

NOTE 5 – PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS

 

The Company has paid $1,720 previously advanced from a director for its working capital (see NOTE 6).

 

The Company was granted short term borrowings from financial institutions for its working capital needs. The short term borrowings received is interest bearing as summarized below:

   

Balance

June 30, 2019

    

Balance

September 30,
2018

  
    (Unaudited)     (Restated)  
Short term borrowings   $ 381,165     $ 40,000  
Commercial bills   $ 280,360     $ -  
Total   $ 661,525     $ 40,000  

 

On February 15, 2019, the Company executed a convertible promissory note with Power Up Lending Group LTD (the “Power Up”), an unrelated-party, the sum of

$138,888 together with any interest as set forth herein, on February 15, 2020 (the “Maturity Date”), and to pay interest on the unpaid principal balance hereof at the rate of eight percent (8%)(the “Interest Rate”) per annum from the date hereof (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The total consideration received against the Note was $138,888, with the Note bearing $500 as a due diligence fee and $2,500 for legal expenses.

 

On March 12, 2019, , the Company executed another convertible promissory note with Power Up Lending Group LTD (the “Power Up”), the sum of $128,000 together with any interest as set forth herein, on March 12, 2020 (the “Maturity Date”), and to pay interest on the unpaid principal balance hereof at the rate of eight percent (8%)(the “Interest Rate”) per annum from the date hereof (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The total consideration received against the Note was $128,000, with the Note bearing $500 as a due diligence fee and

$2,500 for legal expenses.

 

On March 12, 2019, the Company executed a convertible promissory note with Labrys Fund, LP (the “Labrys”), an unrelated-party, a sum of up to $850,000, bearing an interest rate of 12%, per annum from the date hereof (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise as provided herein. The maturity date of each tranche funded under this convertible promissory note shall be six (6) months from the funding date of the respective tranche (each a “Maturity Date”). The consideration to the Company for this Note is up to $765,000.00 (the “Consideration”) and carries a prorated original issue discount of up to $85,000.00 (the “OID”) Total consideration received of the first tranche was $126,000, including $3,000 for legal expenses. At the closing of the First Tranche, the outstanding principal amount under this Note shall be $140,000.00, consisting of the First Tranche plus the prorated portion of the OID. In connection with the funding of the First Tranche of the Note, the Company shall issue to Labrys, as a commitment fee, 92,105 shares of its common stock (the “First Returnable Shares”), as further provided in the Note, as well as to issue 15,000 shares (the “Commitment Shares”) to Labrys on the Closing Date, as a commitment fee.

 

On March 19, 2019, the Company executed a convertible promissory note with Auctus Fund, LLC (the “Auctus”), an unrelated-party, a sum of $350,000, together with any interest as set forth herein, on December 19, 2019 (the “Maturity Date”), and to pay interest on the unpaid principal balance hereof at the rate of twelve percent (12%) (the “Interest Rate”) per annum from the date hereof (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. ). The total consideration received against the Note was $350,000, with the Note bearing $35,000 as a due diligence fee and $2,750 for legal expenses. In connection with the funding of the Note, the Company shall issue to Auctus on the Closing Date, as a commitment fee,

35,000 shares of the Company’s common stock (the “Commitment Shares”), as well as 175,000 shares of its common stock (the “Returnable Shares”, as further provided in the Note). The Returnable Shares and Commitment Shares shall be deemed earned in full as of the Closing Date.

 

The Company’s subsidiary, GGLG Properties Pty Ltd executed an $280,360 (AUD$400,000) commercial bill with National Australia Bank Limited, with a fixed interest rate for each rollover period.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.19.2
RELATED PARTY TRANSACTIONS
 9 Months Ended
Jun. 30, 2019
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 6 – RELATED PARTY TRANSACTIONS

 

During the financial period under review, the Company paid an amount of $1,720 to the directors of the Company as of June 30, 2019, whilst received an advances of $11,210 from directors for its working capital needs as of September 30, 2018, respectively. Funds advanced to the Company by the director are non- interest bearing, unsecured and due on demand.

 

The Company has received advances for its working capital needs from an affiliate in which the Company’s Chief Executive Officer holds the position of director in such entity (see NOTE 5).

 

As for the sales to related parties, the amounts are disclosed on Condensed Statements Of Operations (PAGE 2).
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.19.2
COMMITMENTS AND CONTINGENCIES
 9 Months Ended
Jun. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

Litigation Costs and Contingencies

 

From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Other than as set forth below, management is currently not aware of any such legal proceedings or claims that could have, individually or in the aggregate, a material adverse effect on our business, financial condition, or operating results.

 

In the normal course of business, the Company incurs costs to hire and retain external legal counsel to advise it on regulatory, litigation and other matters. The Company expenses these costs as the related services are received. If a loss is considered probable and the amount can be reasonable estimated, the Company recognizes an expense for the estimated loss.

 

Contingent liabilities that are probable to arise from the recent legal related to the company’s subsidiary Prema Life Pty Ltd, the details are disclosed on Part II, Item 1. Legal Proceedings (Page  16).
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.19.2
STOCKHOLDERS' DEFICIT
 9 Months Ended
Jun. 30, 2019
Equity [Abstract]  
STOCKHOLDERS' DEFICIT

NOTE 8: STOCKHOLDERS’ DEFICIT

 

The Company’s capitalization at June 30, 2019 was 500,000,000 authorized common shares with a par value of $0.001 per share.

 

Common Stock

 

On December 3, 2018, the Company agreed to purchase 51% of the issued and outstanding capital stock of Prema Life Pty Ltd and 60% of the issued and outstanding capital stock of GGLG Properties PTY Ltd, collectively in exchange for 304,500 shares of the Company’s common stock valued at $1,218,000 based on the fair value of the common stock on the closing date. On December 28, 2018, the parties mutually agreed to extend the closing of the purchase transaction on January 1, 2019. The Company issued 304,500 shares of its common stock on December 3, 2018 in good faith for consummating the purchase. The Company has recorded the fair value of the common stock issued as stock subscriptions receivable at December 31, 2018.

 

On March 12, 2019, the Company executed a convertible promissory note with Labrys Fund, LP (the “Labrys”). In connection with the funding of the First Tranche of the Note, the Company shall issue to Labrys, as a commitment fee, 92,105 shares of its common stock (the “First Returnable Shares”), as further provided in the Note, as well as to issue 15,000 shares (the “Commitment Shares”) to Labrys on the Closing Date, as a commitment fee.

 

On March 19, 2019, the Company executed a convertible promissory note with Auctus Fund, LLC (the “Auctus”). In connection with the funding of the Note, the Company shall issue to Auctus on the Closing Date, as a commitment fee, 35,000 shares of the Company’s common stock (the “Commitment Shares”), as well as 175,000 shares of its common stock (the “Returnable Shares”, as further provided in the Note). The Returnable Shares and Commitment Shares shall be deemed earned in full as of the Closing Date.

 

On March 20, 2019, the company executed a convertible promissory note with EMA Financial, LLC (the “EMA”). In connection with the funding of the First Tranche of the Note, the Company shall issue to EMA, 15,000 shares of restricted common stock as a commitment fee the “Commitment Shares”), as well as 86,800 shares of restricted common stock (the “Returnable Shares”), as further provided in the Note). In the event the Company fails to redeem the tranche by its maturity date the Returnable Shares shall not be returned to the Company

 

As a result of all common stock issuances, the Company had 162,278,405 shares and 161,555,000 shares of common stock issued and outstanding at June 30, 2019 and September 30, 2018, respectively.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.19.2
SUBSEQUENT EVENTS
 9 Months Ended
Jun. 30, 2019
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS  

    

Management has evaluated subsequent events through August 14 , 2019, the date the financial statements were available to be issued, noting no items that would impact the accounting for events or transactions in the current period except for:

   

  • On July 2, 2019 and August 2, 2019, the Company settled the remaining balances of the convertible promissory note in full for total $140,000 to Labrys Fund, LP, the 92,105 returnable shares was returned to company on August 7, 2019;

  

  • On July 3, 2019 and July 29, 2019 the Company settled the remaining balances of the convertible promissory note in full for total $350,000 to Auctus Fund, LLC. The arrangement with Auctus to return the returnable shares of 175,000 is in progress; and

  

  • On July 5, 2019 and July 31, 2019, the Company settled the remaining balances of the convertible promissory note in full for total $266,000 to Power Up Lending Group LTD.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.19.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 9 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related party. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. Company had a cash balance of $868,537 at June 30, 2019 and $439,846 at September 30, 2018, respectively.
Property, Plant and Equipment

Property, Plant and Equipment

 

Property, plant and equipment costs include direct costs incurred for purchase of fixed assets and payments made to independent suppliers. The Company accounts for property, plant and equipment costs in accordance with the FASB guidance for the costs of property, plant and equipment to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). As for the computer software costs, they are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Computer software costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to computer software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered 'research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation.

 

Commencing upon product release, capitalized computer software costs are amortized on the straight-line method over a thirty-six months period. The Company evaluates the future recoverability of capitalized computer software costs on an annual basis.
Revenue Recognition and Concentrations

Revenue Recognition and Concentrations

  

We generate revenue from licensing and other software services from our web-based software to distributors and retailers of nutritional supplements in the healthcare industry. We recognize licensing fees and other software services as revenue over the period of the contract at the time that the computer software is delivered and accepted by the customer, the selling price is fixed, and collection is reasonably assured, provided no significant obligations remain. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting.

 

Deferred revenues represent billings or cash received in excess of revenue recognizable on service agreements that are not accounted for as revenues. 

 

Through our subsidiaries, Natural Tech R&D Sdn Bhd and Prema Life Pty Ltd, we generate revenue from distributing health supplements, naturopathic medicines and other health food products. Prema Life Pty Ltd also manufactured goods and packaging for contract clients.
Concentration of Risk

Concentration of Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company does not have the cash balances in excess of Federal Deposit Insurance Corporation limit at June 30, 2019 and September 30, 2018, respectively.
Income Taxes

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes” . The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

The Company follows the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions” When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying condensed balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.
Earnings (Loss) Per Common Share

Earnings (Loss) Per Common Share

 

The Company computes net earnings (loss) per share in accordance with ASC 260, “Earnings per Share” . ASC 260 requires presentation of both basic and diluted net earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. At June 30, 2019 and September 30, 2018, there were no convertible notes, options or warrants available for conversion that if exercised, may dilute future earnings per share.
Fair value of Financial Instruments and Fair Value Measurements

Fair value of Financial Instruments and Fair Value Measurements

 

ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

 

Level 1

 

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2

 

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

 

Level 3

 

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

The Company’s financial instruments consist principally of cash, accounts payable, accrued expenses and payable to an affiliate. Pursuant to ASC 820, “Fair Value Measurements and Disclosures” and ASC 825, “Financial Instruments”, the fair value of our cash equivalents is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The Company believes that the recorded values of all the other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

 

The following table presents assets and liabilities that were measured and recognized at fair value as of March 31, 2019 on a recurring basis:

 

Description     Level 1       Level 2       Level 3  
None   $ -     $ -     $ -  

 

The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:

 

Description     Level 1       Level 2       Level 3  
None   $ -     $ -     $ -  
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses (Topic 326).” The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. This ASU is effective for financial statements issued for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating this guidance to determine the impact it may have on its financial statements.

 

In 2015, the FASB issued ASU No. 2015-17, “Income Taxes” (Topic 740): Balance Sheet Classification of Deferred Taxes , which requires all deferred tax assets and liabilities to be classified as noncurrent in a classified balance sheet. Current US GAAP requires an entity to separate deferred tax assets and liabilities into current and noncurrent amounts in a classified balance sheet. For public entities, ASU 2015-17 is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For all other entities, ASU 2015-17 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018, and may be applied either prospectively or retrospectively, with early application permitted for financial statements that have not been previously issued. The Company has not yet determined the effect of the adoption of this standard on the Company’s financial position and results of operations.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.19.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Schedule of assets and liabilities measured and recognized at fair value

The following table presents assets and liabilities that were measured and recognized at fair value as of March 31, 2019 on a recurring basis:

 

Description     Level 1       Level 2       Level 3  
None   $ -     $ -     $ -  

 

The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:

 

Description     Level 1       Level 2       Level 3  
None   $ -     $ -     $ -  
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.19.2
PROPERTY, PLANT AND EQUIPMENT (Tables)
 9 Months Ended
Jun. 30, 2019
Property, Plant and Equipment [Abstract]  
Schedule of property, plant and equipment costs

The following table presents details of our property, plant and equipment costs as of June 30, 2019 and September 30, 2018:

 

   

Balance at

September 30, 2018

    

Additions through

acquisition of

subsidiaries

     Amortization    

Balance at

June 30, 2019

  
                         
Property, plant and equipment, net   $ 159,146     $ 712,027     $ (111,836 )   $ 759,337  
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.19.2
PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS (Tables)
 9 Months Ended
Jun. 30, 2019
Payable To Affiliates And Drawdowns Of Short Term Borrowings  
Schedule of granted short term borrowings from financial institutions

The Company was granted short term borrowings from financial institutions for its working capital needs. The short term borrowings received is interest bearing as summarized below:

 

   

Balance

June 30, 2019

    

Balance

September 30,
2018

  
    (Unaudited)     (Restated)  
Short term borrowings   $ 381,165     $ 40,000  
Commercial bills   $ 280,360     $ -  
Total   $ 661,525     $ 40,000  
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.19.2
NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN (Details Narrative) - USD ($)
 9 Months Ended
Dec. 03, 2018
Nov. 30, 2016
Jun. 30, 2019
Jun. 30, 2018
Sep. 30, 2018
Description of forward stock split   30:1 forward stock split      
Increased authorized share capital     500,000,000   500,000,000
Accumulated deficit     $ (1,022,658)   $ (1,071,993)
Net cash used in operating activities     (639,781) $ 48,454  
Number of shares issued (in shares) 304,500        
Merger reserve     $ 517,300 $ 517,300 $ 517,300
Prema Life Pty Ltd And GGLG Properties Pty Ltd [Member]          
Number of common shares conversion (in shares) 304,500        
GGLG Properties Pty Ltd [Member]          
Percentage of ownership 60.00%        
Prema Life Pty Ltd [Member]          
Percentage of ownership 51.00%        
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
Jun. 30, 2019
Sep. 30, 2018
Fair Value, Inputs, Level 2 [Member]    
Assets and liabilities at fair value
Fair Value, Inputs, Level 3 [Member]    
Assets and liabilities at fair value
Fair Value, Inputs, Level 1 [Member]    
Assets and liabilities at fair value
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.19.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 9 Months Ended
Jun. 30, 2019
Sep. 30, 2018
Jun. 30, 2018
Accounting Policies [Abstract]      
Cash balance $ 868,537 $ 439,846 $ 310,747
Useful life of computer software 36 months    
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.19.2
PROPERTY, PLANT AND EQUIPMENT (Details)
 9 Months Ended
Jun. 30, 2019
USD ($)
Property, Plant and Equipment [Abstract]  
Balance at beginning $ 159,146
Additions through acquisition of subsidiaries 712,027
Amortization (111,836)
Balance at ending $ 759,337
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.19.2
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative) - USD ($)
Jun. 30, 2019
Sep. 30, 2018
Payables and Accruals [Abstract]    
Accounts payable $ 163,748 $ 69,805
Accrued expenses $ 738,417 $ 38,499
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.2
PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS (Details) - USD ($)
Jun. 30, 2019
Sep. 30, 2018
Payable To Affiliates And Drawdowns Of Short Term Borrowings    
Short term borrowings $ 381,165 $ 40,000
Commercial bills 280,360  
Total $ 661,525 $ 40,000
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.2
PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS (Details Narrative)
 9 Months Ended
Mar. 19, 2019
USD ($)
shares
Mar. 12, 2019
USD ($)
shares
Feb. 15, 2019
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2019
AUD ($)
Payments for Advance to Affiliate       $ 1,720  
Commercial bill       280,360  
GGLG Properties PTY Ltd [Member] | National Australia Bank Limited [Member]          
Commercial bill       $ 280,360  
GGLG Properties PTY Ltd [Member] | National Australia Bank Limited [Member] | Australia, Dollars          
Commercial bill         $ 400,000
Convertible Promissory Note [Member] | Auctus Fund, LLC [Member]          
Debt instrument $ 350,000        
Debt instrument maturity date Dec. 19, 2019        
Debt instrument interest rate 12.00%        
Proceeds from debt instrument $ 350,000        
Due diligence fee 35,000        
Legal expenses $ 2,750        
Convertible Promissory Note [Member] | Labrys Fund, LP [Member]          
Debt instrument   $ 850,000      
Debt instrument maturity terms   6 months      
Debt instrument interest rate   12.00%      
Proceeds from debt instrument   $ 765,000      
Original issue discount   85,000      
Convertible Promissory Note [Member] | Power Up Lending Group LTD [Member]          
Debt instrument   $ 128,000 $ 138,888    
Debt instrument maturity date   Mar. 12, 2020 Feb. 15, 2020    
Debt instrument interest rate   8.00% 8.00%    
Proceeds from debt instrument   $ 128,000 $ 138,888    
Due diligence fee   500 500    
Legal expenses   2,500 $ 2,500    
Convertible Promissory Note [Member] | First Tranche [Member] | Labrys Fund, LP [Member]          
Proceeds from debt instrument   126,000      
Legal expenses   3,000      
Debt instrument principal amount   $ 140,000      
Convertible Promissory Note [Member] | Auctus Fund, LLC [Member] | First Tranche [Member] | First Returnable Shares [Member]          
Number of shares issued as commitment fee (in shares) | shares 175,000        
Convertible Promissory Note [Member] | Auctus Fund, LLC [Member] | First Tranche [Member] | Commitment Shares [Member]          
Number of shares issued as commitment fee (in shares) | shares 35,000        
Convertible Promissory Note [Member] | Labrys Fund, LP [Member] | First Tranche [Member] | First Returnable Shares [Member]          
Number of shares issued as commitment fee (in shares) | shares   92,105      
Convertible Promissory Note [Member] | Labrys Fund, LP [Member] | First Tranche [Member] | Commitment Shares [Member]          
Number of shares issued as commitment fee (in shares) | shares   15,000      
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.19.2
RELATED PARTY TRANSACTIONS (Details Narrative)
Jun. 30, 2019
USD ($)
Related Party Transactions [Abstract]  
Due to director $ 1,720
Advance from director $ 11,210
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.2
STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)
Mar. 20, 2019
Mar. 19, 2019
Mar. 12, 2019
Dec. 03, 2018
Jun. 30, 2019
Sep. 30, 2018
Common stock, authorized         500,000,000 500,000,000
Common stock, par value (in dollars per share)         $ 0.001 $ 0.001
Value of shares issued       $ 1,218,000    
Number of shares issued (in shares)       304,500    
Common stock, issued         162,177,000 161,555,000
Common stock, outstanding         162,177,000 161,555,000
Prema Life Pty Ltd [Member]            
Ownership percentage       51.00%    
GGLG Properties PTY Ltd [Member]            
Ownership percentage       60.00%    
Number of common shares conversion (in shares)       304,500    
Convertible Promissory Note [Member] | Auctus Fund, LLC [Member] | Commitment Shares [Member] | First Tranche [Member]            
Number of shares issued as commitment fee (in shares)   35,000        
Convertible Promissory Note [Member] | Auctus Fund, LLC [Member] | First Returnable Shares [Member] | First Tranche [Member]            
Number of shares issued as commitment fee (in shares)   175,000        
Convertible Promissory Note [Member] | Labrys Fund, LP [Member] | Commitment Shares [Member] | First Tranche [Member]            
Number of shares issued as commitment fee (in shares)     15,000      
Convertible Promissory Note [Member] | Labrys Fund, LP [Member] | First Returnable Shares [Member] | First Tranche [Member]            
Number of shares issued as commitment fee (in shares)     92,105      
Restricted Stock [Member] | Convertible Promissory Note [Member] | EMA Financial, LLC [Member] | Commitment Shares [Member] | First Tranche [Member]            
Number of shares issued as commitment fee (in shares) 15,000          
Restricted Stock [Member] | Convertible Promissory Note [Member] | EMA Financial, LLC [Member] | First Returnable Shares [Member] | First Tranche [Member]            
Number of shares issued as commitment fee (in shares) 86,800          
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.2
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - Convertible Promissory Note [Member] - USD ($)
Aug. 07, 2019
Jul. 29, 2019
Jul. 03, 2019
Aug. 02, 2019
Jul. 31, 2019
Jul. 05, 2019
Jul. 02, 2019
Labrys Fund, LP [Member] | Returnable Shares [Member]              
Subsequent Event [Line Items]              
Principal amount       $ 140,000     $ 140,000
Number of shares issued as commitment fee (in shares) 92,105            
Auctus Fund, LLC [Member] | Returnable Shares [Member]              
Subsequent Event [Line Items]              
Principal amount   $ 350,000 $ 350,000        
Number of shares issued as commitment fee (in shares)   175,000 175,000        
Power Up Lending Group LTD [Member]              
Subsequent Event [Line Items]              
Principal amount         $ 266,000 $ 266,000  
EXCEL 40 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( &Q0#D\?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ ;% .3R?HAPZ" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " !L4 Y/Z4F!'NX K @ $0 &1O8U!R;W!S+V-O M&ULS9+/2L0P$(=?17)O)^DNHJ';B^))07!!\1:2V=U@\X=DI-VW-ZV[ M740?P&-F?OGF&YA61ZE#PN<4(B:RF*]&U_LL==RP U&4 %D?T*E!S[%BZ "4:87/XNH%F(<_5/[-P!=DJ.V2ZI81CJ837GR@X" MWIX>7^9U*^LS*:^Q_,I6TC'BAITGOZ[N[K621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS M[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C( MWXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU M+,76>)7 \:V@S&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=* MY \FIS_I,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_ MT=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=R MSTS0LS0[=R M2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZ MG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCR MHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)2 M56 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYE ML<%5'<]56_*POFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7G MFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5 M' 86%S+D4.Z2D 83 >LX=SFWJXPD6L_UC6'ODR MWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\ MU*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHS MU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\! M4$L#!!0 ( &Q0#D_8MB@#Q@( *4+ 8 >&PO=V]R:W-H965T&ULC5;MCML@$'P5RP]P-N!\*HETEZIJI5:*KFK[FR0DL]$4(D[S65:/7Z<68=IEE^G 1-=\G M4;X8-Y%M5BT_BV_"?&]WRHZR(Q2:O[:/P 8"\0I9 MMS*?Z@=N^&:EY#U17;5:[@X%63*[F08 MH (30)\% A QQP6FJ, 4T!>! $20'%>8H0HSR">!! *AN,0#V)0Q&""N/82*E)[C+"30Q#8N/86+5QZU.H),IJ#Z"B>6"^YU .]-Y MJ()@%A$5W/,$.IJ!OP:(B:K@MB?0U R*>Y]"7[/@)&][S,1CFOX>HV0^97GD"J#X%4"AO=DT3 G!S"(J M^!5 H;U9>* Q3'C4LE'34PMU]OVA3@[RVOCF=#0[]*"/U#=-[_"N@?W*U;EL M=+*7QK9>OD$Z26F$74K^8/?U8GOF85")DW&O,_NNNL:Q&QC9]DUQ-G3FFS]0 M2P,$% @ ;% .3_MN:*%V! (!4 !@ !X;"]W;W)K?Q$@%4ZG5FJEZ*IK7SMA">AL3&TG M7+]]U\9!,#.;YD6PS3.SSZ['/P^[.#?MCVX?0C_[65?';CG?]_WI(NRCZ?M2]:=VE!NQZ"ZRC#/35:7A^-\M1BO/;:K1?/:5X=C M>&QGW6M=E^V_ZU UY^4]OUP(5LM3N5+^#/TWT^/;3S+KEFVASH< MNT-SG+5AMYS_ @\;I8> 4?'7(9R[F^/9,)6GIODQG/RV7<[SP5&HPG,_I"CC MQUO8A*H:,D4?_TQ)Y]FZL;_L^?7KF_J*4NT4I<_+Y^'X_AY MGO*_A\D!. 7@-0"*#P/4%*!(0'9Q-D[U2]F7JT7;G&?MY6Z=RJ$HX$'%Q7P> M+HYK-WX79]O%JV^K(E]D;T.>2;*^2/!&@O>*#5<4<)5D:LL#S.C#@K:/UPG7.8G'S'-S9@5QF4\X- 853SDO&:\4>;$$'VD/J M5D&"EL =(74$?"0 YRB2-D*RI!V9FX#<#@7?I+FS$^<-+J=V!.%'*R2C&#B+ M-:7?I+G'GU+>T"H2A)"KZ"I/>)*!# 5[OVB=R"!#%#@BM:&SXHP$HRS%RD;0 M&>_RE"&9IJ*0KK*"$)MC7,)C*.,3.1-++WI:^3M M::P-YH>KC(/$HXPR?I'CE[XKUBBUJ-XX2_DK"+53-D^T2B@#& U[IYC4I&1B M(B>FH<1$3D(PB)8MLJ0#G7K+H4Q,Y,2D*%PC1R%J@];1ME@0.FVM2RVS#$WD MT+04FLAI^ GRX?<)N_6BTH+W"5=*1J?BZ+04G8HC\1,6VE.62SHP5B=^6BF9 MG8JSTU)V*DY%#5;EE)[_K[MW).-3<7Q:]J-U:YH^Q*3YYYAT'\KM M]:0*NWXXM/&XO>S974[ZYC3M1V;73='5?U!+ P04 " !L4 Y/&N).G?4! M "-!0 & 'AL+W=OV$[=O7-EY$@+:;"^P9GS/^AF"G ^// MH@:0SDM+.Y&A6LK^@+$H:FB)V+$>.K52,=X2J4)^Q:+G0$IC:BGV73?&+6DZ ME*=J3*WP#^;T_?RPRY&@@H%%)7(&JX MPPDHU844QB];$TU;:N-\_EK]H^E=]7(A DZ,_FQ*66=HCYP2*G*C\HD-G\#V M$R''-O\%[D"57).H/0I&A7DZQ4U(UMHJ"J4E+^/8=&8'CG]43_4UXAT"]S$(GS;LS:ZI;H;+W/$E2 M?-=UK.0X2OR9Q']4G-:*T)LD6.T_0?B;$+[Q!W.(_;8_V/0'QA_._>\638R2 MQ$@Z(W%WKNLM&OF?ZH$EW&0)5RQ[=\$R2J+9+I%K?PN>MR@?F*)-IFC-M.C\ M&*UV\F+?2Y(UTY;2BZ+HKTSQ)E.\9EI\5L?XS4Q;RFTF/#L8^J+Z2OBUZ81S M85*=,7,2*L8DJ*KN3A6LU=TX!10JJ:>)FO/QAA@#R7I[^>'I!L[_ %!+ P04 M " !L4 Y/UQLBGJ % !W' & 'AL+W=O$W'WODC#-A!1*EJ@!8(4;9]IF[:%2*)*TG;Z[WND M&$7<'2I^L41Z=N_F]K@S)UZ_5?77YKDLV]FWW7;?W,R?V_9PM5@T]\_EKF@^ M5H=R'__S6-6[HHV7]=.B.=1E\= '[;8+3A*_V!6;_?SVNK_WN;Z]KE[:[69? M?JYGSWTHGLH_R_:OP^E&_-V?=91^6NJKYV%[\]W,R3;D;EMKQO MNQ1%_'@M\W*[[3+%>?P[))V?QNP"S[]_S_Y+3SZ2N2N:,J^V_VP>VN>;>3J? M/92/QS22.<5]MF_[O[/ZE::O=D"5.95=\ M.WYN]OWGV_$_(1W"< / 7P*B&-?"C!#@/D18"\&V"' OG<$-P0X,<+BR+U? MS%71%K?7=?4VJX_[X5!TVXZN7"S7?7>SKT[_O[B>3;S[>IN:Z\5KEV> +(\0 M/H?8,62E(71"+.+XITDPFL2253B/!\@U(G5B#C]-LKZ89#1- ]?*]/'F/-[C M> OC;1]OS^.#6.LCQ/>0?0_QSI,1L%S#V%N?"<(K# 9;&<:XVSF$MS[$[T\JODGN@[6^""Z;XYP ME&2>Q3Y902"%((%K"+2.[41?H@F!(TW22I*$-J])9&O".#*)Y AP+B7O)$6 M,RZU$ZI$4#T_$6N&3C+4&"N?X $SGC5[ELE6[TBV?D>R,3*E .4(&,N<*MU$P+23855 E#$;-?4Q2VP,2#N#3#J# 3->T,1[;R1+ PA MSDIV8@2DQ,0G4143(+/8)-T43>P12)N$3)H$TI)MC2-52@W[X"G-E%% 0,JR M5%%$":.@AJEN@]T":;N02;M 6KE#-"]2<0#,RL=LA7*%X*UD!TQ%XJ;4 GL% MTF:!9(=<$I+M:"8E-YU+4T..(NY/5;F+N<;,L$L@;1.B:DMF0-K)JHV4 URW M,YV<]PH K8\;0=)#^6QJSQZ),4=L%B@#'%ERU""M$C_'K-Z!65_&C ^-V+ZP MMB\D=]J2M8N 90,X7#8 1&6#^2Z4C;%[85(FCY*)KLO8'K!6Z_CLRV4"+)DK=11+.11. >P#]ZYX%)) M4 .M3;W:!C!?/(-G$Q2Q06 +ML'$28^Q^+(67TJD^K)6P6"#5[L B25<):#F MF3'21L%\EQX6++ZLQ5>>KI<,5#5A>?C(02K5Y4"J>#26)ZCUY51C7EAY&2FO M=!6LY1(W.B"KN'8:"!L=RG>I=EB#.=4[G":\%V.)8R1Q:H=G^KS/UF9RE31L M8I4TT';++E<)YION P9+GM&2IW:X 0+E8JL3#$$JM<-!*F.4N;R<:4P+JYS1 M9W3=P0>0_TD'!S!<.0!$'1SGNU YK,(&J#!)CPE RG^] [-Z!V9]&3.F-/%S M.-!=DI;2: $DSQQ2*SU(CJ#=+XWQW"U_(WU_UC7,FI"+9Q?97A9G+TUV9?W4 MO\%J9O?5R[[M6M/9W=-;LD_+;?G8=E]#_%X?7X4=+]KJ,+SF6YS> M-=[^#U!+ P04 " !L4 Y/.O!HK- # "S$ & 'AL+W=O+8:QUV:U<.>N M+&K[VD3MN:KRYM?:ENZRC'G\,?"M.!R[?B!9+4[YP?YMN^^GU\8_)=V<]64Q5NI\I_CM:B'ZV7*_Q%& M!\ 4 -< 7_M1@)@"Q.^ =&A^=#:T^D?>Y:M%XRY1,[ZM4]XO"OXL_&1N^\%A M[H;/?+>M'WU?<2X6R7N?:-*L1PW<:JZ*Q&>_E@"JQ!I0.-P7V&"%D70%038A MAGAQUT1*)TC)!.F0(+U+((-9JT-2#)E4Z#5O!JB>5FI0;VHXD[4BB'T4G M4&0"1?2C@WY&C;QQRCDW0@4-89F6!F@SFC2C"3,F,(,U:6A$8[],,L9H*X:T M8@@K65#'H#H2%&0S"S(CZV3X!<*,4<[H?#AQF3(ZY-4"E0@W%#"U+]N M-K-+^ PL.&$*0E,M2J96980LGX?+"@;"$ ;8$M> '&&9Y\C< MUN4TB[C 2SE<[9/FWH]B1IC0$9%L!@2<)ALGT 9IZ"/BI3 M.C1$**54?&YGT*SC!.P K40L0N#EF(B@M9_(&3LT$GE&V,E".QDQ1R"-UC(T MA94 7*J,-@4T98'AI2AF^@*:B4 P482@!LPZY=U"V!61;&XI LU#('@H0D0# M 3K-I Y9OB&$*=,PL]^!)B)@B'$1(AHP$D& +Q5N#D+XR!)-12"H*$(J @$[ M,"H+H4CH!&?ZQOF])9J*( E+X7?0271G261F=HW0] 2"GN'WOC5@>AIEI$#O M ^L>=D\3%#2Q$>=2T+P#@G?A/]0U(4*\>ZRYMT*S#@C6B9!UA A;>:@9K20W M1[W*-H?A5-Q&6W>NN_Y0=3-Z/7F_0']4#,;7_D0^GI]_IQF/\U_SYE#4;?3F M.G\0'8Z+>^GSHW&GZB2"Y_DZQ^A]0 M2P,$% @ ;% .3[[_^-*N 0 T@, !@ !X;"]W;W)KX,]=/Y/C48+ MYUW3,-L;$%4$:<5XDMPR+61'BRS&3J;(<'!*=G RQ Y:"_-Z!(5C3G?T&GB4 M3>M"@!59+QKX!NY[?S+>8PM+)35T5F)'#-0YO=\=CFG(CPD_)(QV99/0R1GQ M*3B?JYPF01 H*%U@$/ZXP ,H%8B\C.>9DRXE W!M7]D_QMY]+V=AX0'53UFY M-J=WE%10BT&Y1QP_P=S/.TKFYK_ !91/#TI\C1*5C5]2#M:AGEF\%"U>IE-V M\1QG_BML&\!G '\#8%.AJ/R#<*+(#([$3+/O1;CBW8'[V90A&$<1_WGQUDH]0]L<134+ICOO6VF-9L&PO=V]R:W-H965T&UL?5-A M;]P@#/TKB!]0[I*TJTY)I%ZKJ94VZ=1IVVE-2VH)US_8$Q6W6@N+W"'K2_:= H[KQI6F9[ [R.("59 MLMO=,,6%IF4>?2=3YC@X*32<#+MS\.H+$L:![^NYX%FWG@H.5><];^ ;N M>W\RWF(+2RT4:"M0$P--0>_VAV,6XF/ #P&C79U)J.2,^!*,I[J@NR ()%0N M,'"_7> >I Q$7L;KS$F7E &X/K^S?XZU^UK.W,(]RI^B=EU!;RFIH>&#=,\X M/L)%TL:55(-UJ&86+T7QMVD7.N[C=).E,VP;D,R M9 '_ 5!+ P04 " !L4 Y/-1B$ M1+0! #2 P & 'AL+W=O!)MYX*#E7G/6_@&[GM_-MYB M"TLM%&@K4!,#34'OD^,I"_$QX(> T:[.)%1R07P)QN>ZH+L@""14+C!POUWA M :0,1%[&SYF3+BD#<'U^8_\8:_>U7+B%!Y3/HG9=00^4U-#P0;HG'#_!7,\' M2N;BO\ 5I \/2GR."J6-*ZD&ZU#-+%Z*XJ_3+G3D".,0\ M;$H4E3]RQ\OAR=.CJGO3160^?IOTK-ZW0EES0^9>-_6\0'7@INQL_0IW_ M8(LAH7'A>.?/9AJSR7#8SS^(+=^X_ U02P,$% @ ;% .3XLFDVVU 0 MT@, !@ !X;"]W;W)K7;#3VR;4 MGCQKU;FR?,R@SYG1'7QR/LFE]<+ BZT4#W\'_Z"\6+;:H5%)# MYZ3IB(4ZI_>[TSD-^ CX*6%TJS,)E5R->0K&ERJG24@(%)0^* C<;O 2@4A M3./WK$F7D(&X/K^H?XJU8RU7X>#!J%^R\FU.CY144(M!^4)*RL%YHV<53$6+YVF77=S'Z69_G&G;!#X3^$(XQCAL"A0S M_RB\*#)K1F*GWO,'R-61 , MU9<0?"O$F;^B\VWZ?C/#?:3OU]$/R;9 NBF01H'TS1(W,(?_BV2KGFJP39PF M1THS='&25]YE8.]Y?)-_\&G:OPG;R,Z1J_'XLK'_M3$>,)7D#D>HQ0^V& IJ M'X[O\6RG,9L,;_KY!['E&Q=_ 5!+ P04 " !L4 Y/!+0M3;0! #2 P M&0 'AL+W=O!DI^%DB!V4$N;U"!+'G";TS?'8-:T+#E9DO6C@![B?_-*RL$Z5#.+EZ+$R[1W.N[C='.3S+!M )\!? '>RF2:YZQ2R":8XY3#%_'+!',LR\I M^%:*(_\'SK?A^TV%^PC?OU.XWR9(-PG22)#^M\2MF/1#$K;JJ0+3Q&FRI,1! MQTE>>9>!O>/Q3?Z&3]/^($S3:4O.Z/S+QO[7B Z\E-V5'Z'6?[#%D%"[&PO=V]R:W-H965TO&IE7$Y; M[[L38ZYL00MWAQV8<%.CU<('TS;,=19$E4!:,;[9W#,MI*%%EGP76V38>R4- M7"QQO=;"_CR#PB&G6_KF>)9-ZZ.#%5DG&O@"_FMWL<%B,TLE-1@GT1 +=4X? MMZ?S/L:G@&\2!K, MP.7YC?U]JCW4E80< M)2J75E+VSJ.>6((4+5['79JT#^/-[CC!U@%\ O 9<$QYV)@H*7\GO"@RBP.Q M8^\[$9]X>^*A-V5TIE:DNR#>!>^MV!X.&;M%HBGF/,;P9:K!-FB9'2NQ-FN2% M=Q[81Y[>Y'?X..V?A6VD<>2*/KQLZG^-Z"%(V=R%$6K#!YL-!;6/QX=PMN.8 MC8;';OI!;/[&Q2]02P,$% @ ;% .3UHB_\:V 0 T@, !D !X;"]W M;W)K&UL?5/;;MLP#/T501]0.4[29H%MH.DP;$ + M!!VV/2LV;0O5Q9/DN/W[4;+K>9NQ%TFD> X/*2H;C'UQ+8 GKTIJE]/6^^[( MF"M;4-S=F XTWM3&*N[1M USG05>19"2+$V26Z:XT+3(HN]LB\ST7@H-9TM< MKQ2W;R>09LCIAKX[GD73^N!@1=;Q!KZ"_]:=+5IL9JF$ NV$T<1"G=/[S?&T M"_$QX+N P2W.)%1R,>8E&%^JG"9!$$@H?6#@N%WA :0,1"CCY\1)YY0!N#R_ MLW^*M6,M%^[@P<@?HO)M3@^45%#S7OIG,WR&J9X])5/QCW %B>%!">8HC71Q M)67OO%$3"TI1_'7'%/L31F&PO=V]R M:W-H965T#C$^ M!7R3,/K5F<1*+M8^1^-C7=!=% 0*JA 9!&Y7> "E(A'*^#YSTB5E!*[/K^SO M4^U8RT5X>+#J2=:A*^@=)34T8E#AT8X?8*[G#25S\9_@"@K#HQ+,45GETTJJ MP0>K9Q:4HL7+M$N3]G&ZX7R&;0/X#. +X"[E85.BI/R="*+,G1V)FWK?B_C$ MV9%C;ZKH3*U(=RC>H_=:9K=9SJZ1:(XY33%\';-$,&1?4O"M%"?^%YQOP_>; M"O<)OO]-X3\(#IL$AT1P^&^)6S'[/Y*P54\UN#9-DR>5'4R:Y)5W&=C[](CL M5_@T[9^%:Z7QY&(#OFSJ?V-M )2RN\$1ZO"#+8:")L3C6SR[:VUKX =]Q[]^XXTL'8)]< >/*L5>LRVGC?'1AS10-:N"O3 M08LWE;%:>#1MS5QG0901I!7CF\V>:2%;FJ?1=[)Y:GJO9 LG2UROM; O1U!F MR.B6OCH>9-WXX&!YVHD:?H+_U9TL6FQF*:6&UDG3$@M51F^WAV,2XF/ ;PF# M6YQ)J.1LS%,POI<9W01!H*#P@4'@=H$[4"H0H8P_$R>=4P;@\OS*_C76CK6< MA8,[HQYEZ9N,WE!20B5ZY1_,\ VF>JXIF8K_ 1=0&!Z48(["*!=74O3.&SVQ MH!0MGL==MG$?QAO^>8*M _@$X#/@)N9A8Z*H_(OP(D^M&8@=>]^)\,3; \?> M%,$96Q'O4+Q#[R7?[I.470+1%',<8_@R9HY@R#ZGX&LICOP#G*_#=ZL*=Q&^ M>Z/P>IT@625((D'RWQ+78O;ODK!%3S78.DZ3(X7IVSC)"^\\L+<\OLF_\'': M[X6M9>O(V7A\V=C_RA@/*&5SA2/4X >;#065#\=/>+;CF(V&-]WT@]C\C?._ M4$L#!!0 ( &Q0#D\5@)TF) ( 0' 9 >&PO=V]R:W-H965T'76G=;0E15 Z?J2730FIVS MD)QJLY07HCH)].2<."-1$"2$TZ;UR]S9#K+,Q56SIH6#]-25!?O5G'1=^)GOG>!,KTR_B/X+C FM?6_,_AO<@!FXC<1H5((I]_6JJ]*" MCRPF%$[?A[%IW=@/.TD\NN$.T>@030Z9TR&#D(O\$]6TS*7H/3D7"2"2J2( 310@3# MK'"1%!5)$8)X(8)AUKA(AHID"$&R$,$P*2ZR044V",&R\!CF0>'# +]!P3U% MMBP]"GI0^_#!30T1BF7U4="#\H?H==V%$4*Q_ %0T/(/(+,FQ$%>7/M57B6N MK>O],^O4XG>NPY-_\.%]^$[EI6F5=Q3:M$+7L,Y":#"Q!$_F7M7F29H6#,[: M3E,SET-?'A9:=..;0Z:'K_P+4$L#!!0 ( &Q0#D^*&[$>MP$ -(# 9 M >&PO=V]R:W-H965TL"CKNW'V#7=3O_ >[EG',_N&0#FF?; CCRJJ2V M.6V=ZXZ,V;(%Q>T-=J#]38U&<>=-TS#;&>!5)"G)DLWFEBDN-"VRZ#N;(L/> M2:'A;(CME>+F[PDD#CG=TC?'HVA:%QRLR#K>P"]PO[NS\1:;52JA0%N!FABH MJ"D@IKWTCWB\ !3/5\HF8K_ 5>0'AXR M\3%*E#:NI.RM0S6I^%04?QUWH>,^C#?[W41;)R03(9D)AQB'C8%BYE^YXT5F M<"!F['W'PQ-OCXGO31F?0R1K M(4[)?_1DG;Y;S7 7Z;ME]#1=%TA7!=(HD'XH&UL;5/;;IPP$/T5RQ\0LRQM-BM MRB:*6JF55JF:/GMA "N^4-LLZ=]W; A%*2^V9WS.F8O'^6CLJ^L /'E34KN" M=M[W1\9LM\#J2E&1IDGQFB@M-RSSZSK;,S>"E MT'"VQ U*S:#L?'*S,>]["#_ _^[-%BRTJM5"@G3":6&@* M>K\[GK* CX 7 :-;G4FHY&+,:S"^U@5-0D(@H?)!@>-VA0>0,@AA&K]G3;J$ M#,3U^5W]*=:.M5RX@P9Z/E$R%_\-KB 1'C+! M&)61+JZD&IPW:E;!5!1_FW:AXSY.-]EAIFT3TIF0+H1#C,.F0#'S1^YYF5LS M$COUON?AB7?'%'M3!6=L1;S#Y!UZK^7N<)>S:Q":,:<)DZXQ"X*A^A(BW0IQ M2O^CI]OT_6:&^TC?KZ-GM]L"V:9 %@6RM&PO=V]R:W-H965TVRC@'$!K]._[X"]KIOZ!9CAG#,7AFPT]M6U )Z\:=6YG+;> M]P?&7-F"%N[&]-#A36VL%AY-VS#76Q!5)&G%^&YWQ[20'2VRZ#O9(C.#5[*# MDR5NT%K8WT=09LSIGEX=+[)I?7"P(NM% ]_ ?^]/%BVVJ%120^>DZ8B%.J>/ M^\,Q#?@(^"%A=*LS"96 S@2^$ATA@4Z"8^4?A19%9,Q([ M];X7X8GW!XZ]*8,SMB+>8?(.O9=B_X%G[!*$9LQQPO U9D$P5%]"\*T01_X? MG6_3D\T,DTA/UM%ODVV!=%,@C0+I/R4F[TKHQ0^V& IJ'X[W>+;3 MF$V&-_W\@]CRC8L_4$L#!!0 ( &Q0#D]EEM#PB ( #P) 9 >&PO M=V]R:W-H965T[Q(G<1(0()4OM5(K MG:YJ^VS 0'1)G-H&KO^^MF,BXBQ7R@.QS&8-K=4O>\8K(M64'P+1<$IVAE25012&:5"1HO9G$[/VPF<3 M=I)E4=,7[HE351'^9TY+=IGZR+\NO!:'H]0+P6S2D /]3N6/YH6K6="I[(J* MUJ)@M97,A@BZ8.6O8B>/4S_WO1W=DU,I7]GE,[4) M8=^SV7^E9UHJN':B8FQ9*8N)>IBTCUE F*R/60XQ41^Q&B)R MQ\QZ"$E0!PE4KEW"$9AP9/A)SVCN) -A1G"0& P2#P34?]VI1HO!!E,;# [M MQTGY$63/5 *:2@:F,M=3"TEO(CVA,(I2[%1H#0(S5:48=H1!1Q@H$W(LX4'R M3VD\RG('M\(#1TF>X 2VDX)V4L".)POR.!-QJ$-1K!E8AD-O1@IL[0[]7?"/\4-3"VS"I MKA]S2>P9DU0)AL]JCX[J5::;E'0O]3!38][>Y^U$LL:^JP3="]/L+U!+ P04 M " !L4 Y/PC_H=]!0 &0 'AL+W=OGM99.*D6=O!7B)UXIS*]RTP,>0XQ!^-Y_;8 M:-L@1=;3(_P"_;O?2U.16:5J.72J%1V24.?X2[C9K2W> ?ZT,*B+.;))#D*\ MV.*IRG%@#0EL%:H8S[( Q*V1LO$Z:>'ZE)5[./]2_N>PFRX$JV GVMZUT MD^-'C"JHZ8GI9S%\ARG/"J,I_ \X S-PZ\2\HQ1,N2@=@C<&-RN\0DZ4V.NY K&XG71N*Q$?L%5EZ!U2=R+#&+''UT;>9R_.7'0HM^NLW(?*46_P!02P,$% @ ;% .3RU'%4?_ M 0 , 4 !D !X;"]W;W)K&UL?53M;J,P$'P5 MBP>H^3!)+@*D)M&I)]U)44_7^^W )J#:F-I.Z+W]V892 JA_8GL],SN[,9NT M0KZJ$D"C=\YJE7JEULT68Y67P*EZ$ W4YN8L)*?:'.4%JT8"+1R),QSZ_@IS M6M5>EKC846:)N&I6U7"42%TYI_+?#IAH4R_P/@+/U:74-H"SI*$7^ WZ3W.4 MYH0'E:+B4*M*U$C".?4>@^TAMG@'>*F@5:,]LI6UG*B"O6!_JT*7J;?Q4 %G>F7Z6;1/ MT-<3>Z@O_B?<@!FX=6)RY((I]XORJ]*"]RK&"J?OW5K5;FV[FW74TY8)84\( M!T(0?TF(>D+T22!?$DA/(!,"[DIQO3E03;-$BA;)[M]MJ'U$P9:8[NLC"($WRS0CUFUV'"$288$-BH#RG"I12[<$8/[Q/LYP@2W$,.<\@F M7C81+=89.7XTKH&090&R*$"< +EKU&K2J ZS"OR7K9=;SH.EYP/;&S6\)L)DGPZ#UQD!?WK2J4BVOMYL0H.HR#Q]"] MQT]X-TM^47FI:H5.0IM7[=[>60@-QHK_8+R49GP-!P9G;;=KLY?=1]P=M&CZ M^82'(9G]!U!+ P04 " !L4 Y/UR4T2OD! 0!0 &0 'AL+W=O<>S!0C4*^JA9 1V^<]6H3MUH/:X14TP*G MZDX,T)N5HY"<:A/*$U*#!'IP19PADB0%XK3KX[IRN9VL*W'6K.MA)R-UYIS* M/UM@8MS$.'Y//'>G5ML$JJN!GN 'Z)_#3IH(S2R'CD.O.M%'$HZ;^ &OMZ7% M.\"O#D:UF$?6R5Z(5QM\/6SBQ#8$#!IM&:@9+O (C%DBT\;OB3.>)6WA;^#Z.#G"D9Z:?Q?@%)C]Y'$WFO\$%F(';3HQ&(YAR MWZ@Y*RWXQ&):X?3-CUWOQM&O9,54%BX@4P&9"XCWXH5F>RE)GA5H8LEFC!;CR$+#)X1R+#/$B0DL24WY80D M88(TV&/J"-*E?E:&";(@0>8(LO\ZP%XT?F$,;Y//S!4!H7*@%!V)53>;%R9K]+TVA!: MG$@.\N3NHHH:<>[=.[#(SM?]@;@3_0_NWXKO5)ZZ7D5[HEF4M_27V@Q3"]/VA^!.N_4$L#!!0 ( &Q0#D^GD/ 6 MT@$ &($ 9 >&PO=V]R:W-H965T&V>=RE&C=7_"6)4-<*J>1 ^=6:F%Y%2;4MZPZB70RI$XP\3W$\QI MVZ$B<[V++#)QUZSMX"(]=>>5JN70J59TGH0Z1Q^"TSFR> ?XV<*@%G//)KD*\6J++U6.?&L(&)3:*E S M/. ,C%DA8^/WI(GF+2UQ.7]7_^2RFRQ7JN LV*^VTDV.4N154-,[TR]B^ Q3 MGAAY4_BO\ !FX-:)V:,43+E?K[PK+?BD8JQP^C:.;>?&85Q)THFV3R 3@J:9%),7AR/*R>VCL1G$+S,4O;=-_.K9FTRG0?!2%Q MAA]6:,(\CQBRQ/R+.&\143!#L#$PNR"[+HCCAPM^$/O[ N&N0.@$HH5 G*Q2 MC)#$0;IQCR0\1.DJRA:6'%,_WC<3[9J)-F8(6;N)-ML&UL?53MCIP@%'T5PP,L@A\[G:A)=S:;-FF3R39M M?S-Z9S0+8H$9MV]?0,=8M?6'M,U@ G>!6]UCFICNCW&NJQ! M,/T@.VCMD[-4@AE;J@O6G0)6>9+@F(9AB@5K6E1D?NVHBDQ>#6]:.*I 7X5@ MZO<3<-GGB*#[PFMSJ8U;P$76L0M\ _.].RI;X4FE:@2TNI%MH."(/O(OLS2+?IWYY_9M-JNW@I*'S-\?#HD^RBI.F)*'+U&O85FH\VU7N M+__*U*5I=7"2QFY0OXW.4AJPBN&#E:SMP3(5',[&31_M7 V_UU 8V8TG!YZ. MK^(/4$L#!!0 ( &Q0#D]2)U?!QP, 83 9 >&PO=V]R:W-H965T M,]\8<;I*D MV^Q5773O]$$U]I^=;NO"V-OV*>D.K2JV0U!=)3Q-LZ0NRB9>+89G#^UJH9]- M53;JH8VZY[HNVE^WJM+'9?RZ>]Z1\DJ\6A>%+_*?/E\-#:N^2<95O6 MJNE*W42MVBWC]^SFGN9]P(#X6JIC=W$=]4UYU/I[?_//=AFG/2-5J8WI4Q3V M]*+6JJKZ3);'CS%I?*[9!UY>OV:_'QIO&_-8=&JMJV_EUNR7\2R.MFI7/%?F MLSY^5&.#9!R-K?]7O:C*PGLFML9&5]WP&VV>.Z/K,8NE4A<_3^>R&<[',?]K M& [@8P _!_#\:@"- ?36 #$&B-\![&J ' /D6P.R,2!S I)39PV]?U>88K5H M]3%J3Q/H4/3SE-UD=GPW_<-A.(?_[ !T]NG+BE.Z2%[Z1"/F]H3A$PR;8M8( MPZ>8.X2A*>8#P'"'SSW*(\Z8Q+;WW&@.&\V'!&*20#I$3IALP#0#AN473"95 M"%8AKTKFMO8$D1=%^"RE+%!&P#("-";#"21,(/_,4WJ=<8UG!LMD@&>.$^0P M0?Y'GO>YQU.D_8'+S&"9&> YPPGF,,$<))@[DII[1$F&B;(4:S?U*PE/O C$ M G4"'L% "N[602 *U,&R9$"70KAU?&%>[3JL3>:+DPOIEO+E.90*5,+R9$"? M(G,K"5]@N0P5PC)FOHZY" B,88DRI-&YZ_29QW5V;0"PF)FO9BYF;BD$F@?J M8#4S(&=W[JXA*#1WL>@94+T[=]?,EWV>A6<4Q[+G0-'2D?UZ!$EWE *5L/ Y MT+0,> +K5U@4J=1=PA',WL$*&'MW#G)P))X9*Y#IJ2P1;"D86XDYC[FP$\6 !W;;"P)7%@2:Y1KT?0Y627 M/I_KH"D9;%H<^5'FDLG]31U@XV]5>)@.]C8.;$O*0 IL6_PMMC6"Y&3$LZ"9 M$+8M0AL1M_/(MRT*%\*N1U M439E^LXFVZMB>[ZIU,[TE[F];D]?9DXW1A_&KT[)^=/7ZG]02P,$% @ M;% .3T(L%^6O 0 P@, !D !X;"]W;W)K&UL M=5/M;ILP%'T5RP]0@T.3*@*DI=.T29L4M=KVVX%+L.H/9CNA??OZ@R*6L3_8 M]_K<<\Z]V.6HS8OM 1QZE4+9"O?.#7M";-.#9/9.#Z#\2:>-9,Z'YDSL8("U ML4@*0K-L2R3C"M=ES!U-7>J+$US!T2![D9*9MP,(/58XQQ^))W[N74B0NAS8 M&9[!_1R.QD=D9FFY!&6Y5LA 5^%/^?Y0!'P$_.(PVL4>A4Y.6K^$X%M;X2P8 M @&-"PS,+U=X!"$"D;?Q9^+$LV0H7.X_V+_$WGTO)V;A48O?O'5]A1\P:J%C M%^&>]/@5IG[N,9J:_PY7$!X>G'B-1@L;OZBY6*?EQ.*M2/::5J[B.J:38C>5 MK1?0J8#.!33UDH2B\\_,L;HT>D0FS7Y@X1?G>^IGTX1D'$4\\^:MSUYKNJ4E MN0:B"7-(&+K$T&S&$,\_B]!5$1H)-@N"_'Z[3K!9)=A$@N(OEYL;EPFSC1B5 M1';_LUFLJA0K*L6-2O&O2D[S6QFR&'^XW3^8.7-ET4D[_R?CO#NM'7C&[,Y? MF=X_J#D0T+FPW?F]2=&ULC5?=;ILP&'T5 MQ ,4V\&85$FDI4VZ29M4M=IV31,G007,P$FZMY\-+@+[(R,7 3OGG._XYSBP MN(KJO3YQ+KV//"OJI7^2LKP/@GIWXGE2WXF2%^J7@ZCR1*IF=0SJLN+)OB'E M64 0BH(\20M_M6CZGJO50IQEEA;\N?+J[=>WHH;T*\ MZ\:W_=)'VA'/^$YJB41=+OR!9YE64C[^&%&_JZF)_?M/]6TS>#68MZ3F#R+[ MG>[E:>G'OK?GA^2>*;AVHFKL1%8WW][N7$N1&Q5E M)4\^VFM:-->KT?^DP01B"*0CX/ F868(LZF$T!#"J01J"'0J(3*$:"J!&0*S M"$$[N\UR/28R62TJ5B=[8^)ZI#;'3G(A9N-B\-RJM05TAH@G%Q'B#A*H">EFA8"S0AI^ MV./'R#+10F@#*1H(1>9CF9F"''B:@9YFCBD^!^M7B M1U(=TZ+VWH14#Y3-8]]!",F5)+I38B?U-M,U,GZ0^I:I^ZI]I&\;4I3F=27H MWIE6_P!02P,$% @ ;% .3_0[=:=G @ Y @ !D !X;"]W;W)K&ULC5;O;ILP''P5Q /4F/]4!&E)VF;2)D6=MGUV$B>@ M F:V$[JWGVT<%((SR(=@F[OS^7[&D+:$?K <8VY]5F7-%G;.>?,, -OGN$+L MB32X%G>.A%:(BRX] =90C Z*5)7 =9P05*BH[2Q58UN:I>3,RZ+&6VJQ)2](N;&A?!]Z+4\[E ,C2!IWP#\Q_-ELJ>J!7.105KEE!:HOBX\+^ I\W MT)4$A?A5X);=M"VYE!TA'[+S];"P'>D(EWC/I002EPM>X;*42L+''RUJ]W-* MXFW[JOZJ%B\6LT,,KTCYNSCP?&''MG7 1W0N^3MI-U@O*+ MO?IO^()+ 9=. MQ!Q[4C+U;^W/C)-*JP@K%?KLKD6MKJW6O]+,!%<3W)X _?\2/$WPYA)\3?#G M$@)-".820DT(YQ(B38CF$F)-B.\(H"N'JN\:<92EE+06[;9H@^23 )]CL8/V M;%A/&&F%<3 MQA]BWDR88(C9F#!ACP$BMSX\UQB>JP3\@4!D%O", IX2\ 8"L5G -PKX!@=W MY7OI,*'"U H#?4?\[M*8A WL!$8[P=A.=%>]98<);N9)7.@$YFE"XS3A>)KD M@<_(*!#-SSTV"L33N:_B4:!>,,Y]/0D;V$F,=I+IW%?)*'<8!6,[D["!'>B8 M3Q7'4"'X0.+!P03GUPB:'T]H>CZ3^\/$'>7OAN$HE[=I7&<)W)R\\OW_'=%3 M43-K1[@XQ-51>R2$8Z'I/(F8<_')T7=*?.2R&8DV[=Z[78>31G]3@/[#)OL' M4$L#!!0 ( &Q0#D^,%-01:"@ ,*X 4 >&PO_HBNKF9&J()FDK,O.I(JF*%L9B5)$*=[4UGX @2:) M! 08')(UM3]^W]'=:%PD?>684552MDF@^_7K=U_\-DTS\6$11ND_OIEGV?+5 MBQ>I-Y<+-]V/ES*";Z9QLG S^&Y$N$^GZZ5S*;!&^Z'4Z1R\6;A!](_(H M^#67@SB/LG]\TSOM??/=MVGPW;?9=V>QER]DE DW\L4PRH+L25Q$O&801V)/ MI',WD>FW+[+OOGV![_![I^(JCK)Y"N_XTJ]^^WT>[8N#CB-ZG>YI]?B,\UHUSTZ/6X]QMW3L@9. MM[/W0^L+-S()8CRZ+\[P&K5QP;Q8@'$-,YB[Q='+-U$ M/+AA+L5V9Q]0*)8R83*K+9^X?A#-Q/AI,8G#VK6^&UZVG.8B\N)D&2=$- YL M#*@4<2*( Q*XVMBO4\F/K8ME,G&]+'B0>">N&.1) CBN/OY3G4W4DX#=U -* M^DG"T=NN=F^O<[IWT&DE<3A.1LB P^1I&Q#J\?'"#4/Q)D^#2*8UL+(D;Z.# MX4(F,]SF;1(_9G/ U&+I1K4;U4]_$'!'41J0L&#:74%@< %P\%F MZWD2GH$G?'ZZ[6QS"6=;#5B9XL8DP\1UGJ49"#HX7BO_J9M2;'@.']>P]\/! MNK?IGAO?;6+:P?7H;#@:#\_$F_YE?S08BO&[X?!N+';N(S?W \#'+@CB^_&9 MV-G>K;X]EDLC:T_:Z*^?IC*K4Z>;SDGP>_@7^6L> %O"X[4'^YZ'C",2Z4EX M9A(",O=$-@\2'[DY"^J4W_Q*(D.ZWN:74-&]2I>N)__Q#6BR5"8/\IOO1'7I MZVP.E&0OC&?P@4& #FN 7$0/<*0X:8#QSOT@W$;,W,497.-J[-TDH(&3[ D$ M6N@J#8HX7"(E."*2-=Y\&\?^8Q#6!!GOABRP>D=^KN4NU9N7@3L)PF#%E:2 M_2?$6\/W(!?@$!_ LJ@KBAM^2V2Q<*=3V*-!AIW)J00X?+@=P#I(^#54TO#\ M:A+Y;CP',2A ("_$)$Y 1@$SUT_J/[B1!X0Q3>*%\ .@%:" .LY 2,C$"P"I MD]9KV0"QYA09$%18/ >GL2\U;%^!MUJQQ1 (:YU>U=I4JU='''8Z3H?_5W:< M/NL[AX:']<9"F2!GX;5P(4>%FXLI-O+DX MZ+(Y1T^ 1,HD&A)&+#EPJ^E2D@H-:Z?H^S[I#Q2[;N"+( (UL0P (PT4FB]R MI@]?3@,OJ/'8>9S(8!8)CY#N/0DT"].0K5DE4ZKO7('*(XG2^"W?C:0+@!-G M23#),\T)\6,DDQ0M(!!*;3H)B< #3!>; M:)2=&Q?)%% 7:VQ%\RY)SO7:U MGUPIE)G2]--U-*9$!:C,4C&.P]K)P'),4P'J<5IGS^LE&GC(!$/6,NFK^@91 MFH?TS%36][^4,X .:1]U4,M#)!$%X!#W:/02/! M9Y9X"0]!BAP*^[2@5 V+QN=$SQ$5:C7*/)Z$R&O MD&NN>>6V39 KB-=",W23"(V>0FQN*$S? Y+G*!_Z#T!],^WNX[GJ#A((B3=N M&GA$Z&=!F..+N \KB+JD;A&:@_[XG3B_O'Z_H3M#/LEY&#^F)4X!@/IH/I#F MJZ$$R1+17K7%C75D3H:PC+O0-TS7OW.1@X+JI+.[Q;^YB M^;K])OL>?*/L(D1X/DD#/W#1 26O$#_T-O6\">(@FA8P+]A8)8U5[-3H;VZ$ MMTUP4,6;L@"+=VK2\"QQ'WTPCDEJ%HY:(Y@ C2>EK]9&VBWPS'H /I<]$=GXNWUQ>BM #4Q&-Z.:AHVF;F1$IB.0 LP#@._ M$*@WZ)O!V353%2Z(,9'3%3;RZ/IN*+KB;_]UTNMV7XO/ EV,W"Q'F_&==,,, M$.\F"_$.SR8#7?;&#]XB;]3JOE;5 _^J^=O3'[V7UDXLL-1_AD=7'&.16 MG^^*1S$[J.Q4%2X>RI&\L'U70$X^SX/GT27O8V78@? ME$LVK^#1W7UQ5Q@V J0=>-?@J8,.\,6CG.Q-7)0<$Q5-9E7@YI$W1WF2I3*< MHD\;T^9S0HN'9DD0^:!^DZ?Z\BA(2?LJI0MO)G$^F^-J%8F9R,P-0A'E8!6I M*$%JF &^CXET/*!5\$<<-']2>@@A8$S&9),R7/0Q[NKG7I8R8)X-F/)HBX,! MD!,PRL0T#P&%Z+K/&/<(D>O)G-QG,0GB3'KS* [CV9-9,D;;%06#WI$ TGZ: M5N;F]!;NEI1Q(% 2%> D];B7Q7MD%( >J, ?@00@D>M2*(,",ZRKU&V2(12Z M$R2>.,'#B"LW=)_2P'5 ^ )'S8-42K%P(S /Z6D#HMZ$]$XD^GBQ+M@#^' ^ M!5AS.B?\#0V$)W5@/GIQ$B!%0&*$'!0O7?!"V;Z<@RS2_UY(/_"0SO;%=21& M\4,IE'3DV#8XNH 8EA*>!'MK"A?!=.^:-!C<'I(4.KI>R.(RL'-#XC$ HL E M%:^,I8<4ESR164R,A&88&4:T5 2+LZ;J$V#@[>9+YGMX<+UP("L0R (P1D3@ MPM%>=5'4/KK@D[-]EBX!B01L1J@O3$-\/5#ZR^>SF:B(\@8\#IXA.'8 <.<< MO8QW(#(P5'D5A"&T/(#;;I,'- #%+WG!$DD)A^CC&!6/&US&8/,5DJR_A1 M)D0?''[$Y6&38\=2#!=*^&!R&$.&2/!]1A6LOW-^,;KM[Q:GRXB1E&#E2U:7 MOLFM.N6% LO :#I&].41%?4\%X&/!J1.HYLF))+OI$4@6>,/>1P-#\F!? M]%&J PHIE($"$,"%?QH="LM, CZYTN(*^2I0#'>-6C@,)BHCRCDN3'P$$7/C M6<%P)6YQK)@) )P]2AF)I79C4'F QE7A)UH6G1*XGEF $0?M[NE;!*#1<4Y\ M\AVT^Z%BY2E@(@"$N@OT[-AEW3X$>COH=/97XAS.)]X$\4A^R%.3TE845-)+ MF#< ?@9F(;_4:#;&A]%KCO P:/B@3$CY@2Q!;3]Z)M-C>>4E!0Y70Q(UCK0& M L"G.2!E<^IPE#E#BG"U.F6@V+=GB-,<#X46"-@8>_%T+W518:5/*=BWE$ ! M#O6(GA.=?H%%%F[RBT2A2)QY!MXWJTN;,S5>W5DB^8X,-1QV_ZJIIR7'H[6) M"AQ,T19?N,"K4_!50))>9OS.4>>C5WK[]O*M4&E4Y""U'%PE<)?.%N&ERP]* M%J.@.NB\= Z+U%2+IK!%61DUO1,;-RH&+A8YZ&/DZ0))0$.@%%GF@+N%1_"5 M@4%O:AS:+!X7TE&EQ,K&KT)-_0PU11_7;Q-1,0,S%ZPLU*.(##8%%QSXL*'2 MIJ'6:* *:SF*(JO5 "NO &5K"X)H('A,^R!I1K MF(/+$*&K&Z)PRA.R/:UG0:0!JZ1X#>1DT*D0;4G(5DP!N+;X4>5\GT?2U*VQ MML6'X77@4T)0; +W*L*;((-SF@8%2)_ &ZT5R7C21L'=*- M:O>9J]A,BE4+'PS1 O^2M$8[D%RV5CI&W@KD@U3GQ6]L="DBYV/#EV0L;LQ> MKB]_S95OLG!_D#"!( ?2K+\]BDA-,T3E6XR;Z*FF6), M(:[PB0V!X@ND@90WX%!UZ40U8FN@T7X$LC)4Q6W*FS,^POI[$)S86HAN9^^? M)8FIA?R^>!LCJ0QBH*DDLF6Q@:L5RX8R.R5MWT<).U66KB@ST-HJ< 297T'@)D)-; M8T]8!;F+*""U2KY-B&',(%.I#U@K1XNTBB.MW.@!UW8%C*E3>T?I/12OP*MY MX4WP+B5FRY=,CQ2/1G\"U;3V5@E.70"5LA7!N*ZZK50@,B$16NBCJ0E1VVL[1X8G2/"5-1? <2$A@F/BH&. 87&4$1C+R'^O8KID#GDF3-TFJOV8Q*ZV6(@P+2.%"U+<7]U MU;_]"8/HXXNWHXOSBT%_="?Z@\'U_>@.@^@WUY<7@XOAN"4WB(O? $X]A'A- M/+\G]L3F&]+U36.4+Q2%0*.9@WQI,(L(:YBBM>2Y!B.N$96E7&.\AR U%BZY M\L;C:?%-FJVMNU7JEE4M*B6FE&4E(=*TC66:/,YC=N33);K_>+7*] P2%=/6 M)!=/?I8J=Z:YN0DK0 )H,Q &&I5@@[9RA$ ZP0>(GN? M*@FU*K+,/KP'."S'+,'VH@U9AVO!4N+?YFNX9]TX3+-@00#BO? J!MN-UQ1$ M&BF(2K)BOAQF[O?'8,H 7G8! 129*=VO-@.E@9JT%#B;"\[T,_N[%!C4) 0J M#N6(DB!EDR*LU!D6IBN'*NE0U#?4\HZR>"U_>:4IV01.R>C0-43"S\UM)J8G M@JMLJMH0+7MT^"2&$ DK[?C1.1EE]_(;VM2J%$X[^ F52E?1M"QJI.UBO$H& M#"--*1D6[?#$NAPJ(V4*RG,.Y!TGE&Q"9"0!Q??PO0<@\#A/5:)+Z5Z^\2"S M_!#*9&%@.F;I7F0/O2 !;8]RR],FC>7TLD'*[$[^)T8+4'X S2'V?\[]F;K. M"=H;M**;),1E%+Y=1UZ*-Q-T!HB^TJQR[4R_"3D=> 8_8#YW&45HJ?'Q59A, MZVN,ZIBS%'BKIC/@*$\J;&I$3:BR73XHY10C4:UNM+E&V)7IAV)'&?M&!+:1 M7U8]FPG.TALE4LAJP#O@K5'\ICD:@7T%E*@D%I? "ZWE!B5:U.'@E*3L'.P# M.&@8P-,HE3!JQ#=+\FR! 5UCYUJA#Z"%D#+#?/EP$F)[4\O!I%'!<"\W0L;9?@M%Z\O((OUU7'::/5+J$D$B M^?,DK%0F9^JOK(#VL##ZGD0D4G(PRK5QHB/@6&"E"MQ;RJSTI386=[UG',&)_B4M&+$O8R6@;FJ.1[=4 MIAH=G,, 0,FN,.'T.NH#3ID_$/-QA:QRL)2UYP'(,?A4;.*"41)<:(:FL!9.+:(]Q03?[J/(#1HTLW\QIK%5( >GGE'7%-N#WB\N==JK/"Y3N@=FH#*-+:& *+\-TE^L^B;; M."<4+V-T.=AO ?S]K#U]*QCME04-BC( "@@DP;55"$6'*F@A5:M>%I-@)7K* M@242(3L370?Q*T@[%)*@-W[AC#%X-5G>$*OV8\H9JD0@>XR%]9^6J>U<^M2F M=<8]WN(B AXDKAE8I7PAE@\U^PKK_0.[(+K=!B\ZH^ IS@J1@<"Q6,NQ?=+Z MI\$B1_/X^&7'5/Z6]E:&<@D$#ENR4EKJ3BV.#_%2>UUK-2N4BB#?8ZB60M_% M-J9Q,Q6FFTCU+=W@D ;55DR56F5GD21N2ND%:=X,ZYL\FD9$WU]24: M-:)K_N1H8JJ"O>C/H;MK13 0S1PC*?S]7_.8[?9 4;,:(,+.DJ(F]/W(!&Y< M=U]!T#-_?A(D001WIH-#("FB"FQ&/L<3E-ZN%1Q6A&UM\F3JE,J+4&\2\%_H M)BV@U5#PNF&)-1BA C2%0"(KD"_Y%'-3J+H>XC!?T)B7()IBE)1L_J(X!RF5 M@A0E,'9?XQOD1.WI>@D3_:,=&:&VBEQY:DJ'O(Q_.P&V:B M"O@GX'1;2S!, U33:KX0XH1<>5<5.,<^]H]9%C(S?:"FS@:+HA>,&\2"GW M4[EG*QFGBV/R,.01"W$;")HV#\R?GT2;>60!H[!:B\"R).7">D.L]G6H-Q8% MDG 50%E\:N%W\'6"!Q1L4UC"OC_W^X,-?/A^$N> ]Q!FOEBI4"3.(*_>^J" M+R(V:8K^!PKHJ5I"Z[TQ)A[=!"S,^R6E7HJ(W+U)J.$J>]T#BZX:5>R>&+!M M>,FU' $O'G8L/_X7HSB??IV#TO-5YDU;U1T=TRU:X-:QMJX)HV=:3>WV+!U M]Y,C;BXISSLZ$\,?[B]NL-VX?3Y/4\1W37+YP#2+K=R3DPP4 2I%!1ICQ:IU M@W0&4 LCDYE$T15N5QJW5<66KD*\8X*!R2ZV,X)-[S^F"?+,H J[J'IT[WY1'\[;C;(Z]#9VEC\BOM)I!6!U=7Z#VE..EX;:-]M0BSZC939T^ M;D>!KX=]>B?WY^<7G1O\-S S+.;OOOSZ[?CZA5=?SN^A:$T/#V2KRY MOKV]?H\C+=L&=]V!36'JUFC 9M&E?8TS(+#F[0[-OC>MD[7HN@X+X?@98-:; M0K'E>+OK'/ M6 QL.\E/!S39\9.PSH":A$B.XOV,&F"P+TJ-+9BKUM M- F!&J\:!HGQ'F7#3\+L'F=-VI>M BAI6;V$W JEZ50,246(Y%8X8)\ M(_S*DL\HS[J@+0UVNI548>'O;C5.2P/I=W#2=;I'A_"WE]1@ME49A8;/]$XZ MSL%1!TV4+9Y7LBV.<#18KW@/&RO.Y23AAH=#7>5NAYWD!S"2N-$13.<';/5@ M_11C$2]VY5$I.8FG&^SK ]L%;"4NH.+FRLN[LU)/M7Y,FS08L0570N6!]D@K MJ@AOON"B16"ZDQ-DR!E'3[D\)WHJ[@/O 50'7#(&LZAFVJ'ZXO+Q@#9M4*YT M1AQK66UX.$WB6AO$ND*,Z-RX#R;AC7MBH%;5YZC*&9K9@D$2LA%W3OZZ:V^O MF_/%K;4]A50P\[ H[ 6R!M4.I070ABL!+]"6#%5-\4*JCC>LNY&V[^*80#26 M%9JZ@(23.F:4)ZGY!,/O5$+UQ,Z9E3UFOLG4/!RK-:W@&IU&1)!&1"MP5_I* M':N#%[_3;+6-[37D)B/@/DB]&=7+3"4?8[M'#3A3JER8J9H:%.YV6VE/$W0; M24<<5?EZA%TBXMX)\=PG$+%]GF<*_J-0,-_G;T/!GRJ2+]U)\I2*\SSR'7%Y M4T(]?[=:"KN:?('B 6K\+/.>W0A;2$X5.K (8%2ZZ>TNVUG[")"*/+;M M PYC;G)$C$8JCRT*Q $[F.C"A2*5VS:B1]-.X\KJ0X2M+$D84+XDN!46" Y+ M+>QF#7CX&H@L1YSVG&[G<%7+JWV3#,"M!-KD8E4>46<)F]2TKQG.4U4*#"<\ M\(B#PET**3.,W=)4V\J<'@UM>:?B7%K_#=1E([\TGM46P*>?*X#[V+9K!/#E MH 0U?[FA!-X^T++W$RP(TUFG3_3;&A$97.6#+*P(T!"[XM_-CMC]9%/"W&R+ M*7' =+_:FC@^;)9QFTF,M<)!$?*F3.2(@Q*S;M#GOQE#ER1#][BZR4JIU":/ MUHHC=;6U]U7]5P740@'X6$7C4ZY==53G#+A&AX5&VF*KBB 38051T#)PP79H M@!"4W[_3OS_;?LD#:':M"1H4(& R&.G)+684 M1H8(3L6FH*FJR*N-+1Y>]N^&9^*F?WOWD[B[[8_&_0'-;*L/..9"T!L4?/S# M%#KSNR8 >60B6NV[B;.B\\0:'\ %:ZS!,6@E'\M<0&(.LWP+;<&H$)4$6.,5A[ZRIN(B76%.AX-PL1!"\L^-%"''PW*).P]Q MJ;0#!:9M6'=O)F8X *<6!F8$@#7?\'IJS8T6.S?]MT/1VZWQR^#ZZNKBC@?P M8B1V<$V=D,-14]]E(7JT*%*=7=3D5V25US'0L6&@E=N#9,A4<:08F*18>=-S MTM14Z1G3GV5^PD8=-84IB![B4)4FZAXHG(.8!SKS2YILR?-%>?ZHFE>4!$6E ML40QZTQD=+(<.B M6SP/@S.M'IRSU?C '">.%4#QE&VJY2G9:Q0]=NS&0'0IN8TL?.("S$3;##FY2Y46KD\8!SR-# MNL8,I#Z&8TE1''D1F"Z(HDU=]3J1#8+[M(XP*-,()553E2T#9,Z#1!:USA%U M9R6HM_CLZ%NFD@;F *SV57JMETE [R_#KY'5-0*** M%Q<7CK@ Z2BZ6(Z$.]Y85+P##\W Y3NJ=:G?70_^B;__-KP=_UV<#<\O!A>U MZ@'^88UU8N_DE;!7TVT=:LW&JB)3)N V3ATB>]X>_6?-"M1F*=N(RK8J?E(# M]7_E!]7V2S^$]6\P(0QLLJ\Q(8PQ2,4_VVA!<:#=3(3+&DO)JN.Z[$"03_;X MEQH[]B>:.%8QW;@280/\:8I(]21+$ ZZE$H;@3K57T#9U5-^?I>(]W,P[=\X MF/8<]_CSQ#T,A?0Z-H5XGT APZM^41!9IQ'X^K?A?MC(J7 8M5UA[Q*-;BS= M50,=B8^FB9,CYV2CW3:AC/5"9==8]=B=5>Y5FI+51VXS4@*7/"H,3IZ(5LN9 MM:R1R!BGZ/:0E8Q?UP,7?34P'=TT](O"L*Z9K+D8]L@"_ &]WO&)\[(0Q4C7 M#3^@%T^;U5U4^T&]3VA>JH]A>C,>_G"/]:G#']$1K_^:Q"15_1'#APU^.V'K MU+CWM;7ML;BH](OV[;3813ZH/C4N NWGLSS-MKHOAFO@=2ZUV M$:4%(7EN7).E,H269M66"V_.EL)64C"']A_(0BMX0DO+.-*'X+'AIZ]K!SZP M#LP8T$FAKWYFP%*M1YFKD2Y*@(X!$LV7K?!(F>%H%3Q4=6':@E"*5Z2$P M8).GZ6MJ,:VBX+"* MWA\!M<>>_H2..@O;#H,X:SB1T]@ZWV\US5Z5CKOG^> MGO4\/>MY>M;S]*P_V_2LC7^[:^,'_Q.G;GU42];']6\]3^QZGMCU/+'K>6*7 M?)[8]3RQZVM-[&KY!?4U [Q:WMI:._9KZX\P]FOK=QW[M:7 MYZ ]ST%[GH/V/ >MI?CJ>0[:\QRT/]@=3R?,8O)5C\+[D_+&- M+OV3QW!M3 K/0[^^UM"O6HE@_^[^=HCT@**@3]VRCGC3'U\0D=S<#L<@"^AS M(J&WUZAB!M>CP?!V)';.%&N.L'0+79)=$#/WXS.QLUTCH3/I[8N.ZDZHP1$_ M[&OLU+I^;&&'V=XX>00-K[L-P&:O): /.J^ZFSP'^CFA+*O=J\-!!T4M-4#U MK[/F*4=8FWZ8M?923K>/TH(KUI3=L!/HEJ :MAIBDSCVKZT-_'^NB,#J):!F MYW('$I>MT0\QKP#B8W>[X1D/V+N%POHQ@BWFP;+ZV!&V.OUU@Q.W[7/8;5K@ M8TPC1;@KR+5P51PPX]"MZK>]\ G8V8NN! M%=!M*"GD&:5353U72?_4V/9()0P_TE+1MUE]#<2QD2JG+?!;6GHB9T&$4<3: MO7Z,$5![V;()5FS.1:"?-,CUXRZL7W'GOZS]L)ZQJJJK^CWIKJ\"E(6>ZOK@ M/.R;)B4%. O%YB=[&SQY+B?[9K)F"S)*%-J_;WSF1AU M8IM;+XUH$/_7,/Y#V.,_6J7(%UP:'C5/..(,K'\WJ=?D6>75-T5Y-8W(*2U4 M:0YK@_],3C(K%K;FZW*G2J-! S2S]9>_X.VM6ZLT0Z7Z<+?7K!*I)UJ9N?X: MV*O#@:H/7):& WTBIJLMEALBNL D&K>US=OD_G7S,+E/A'W%*,^V8VANISON M==I8O.7KDZ9+W1#8H6&ZO)TC2EC:9) M?)PQ1?)!MZZN-"I6VA'5+W_4^9X2^=>DHW:P]' ]<+P^5F%_!5YI)X%6PODB M_/_5V+Z=L38^T.=SW!? ZI=B^R^ C]NB/YGGFY1.NA&8#>W>7Q9=7QW&+X;- M>F=OLQ"K-@\7.^UM=J)VIS*?[8O.<;,T^SX/]TV?:>.7*BQ8^Y*7;1&2]*;. M]S0O>[CJRY9E5Y#_YAJVCNE+K)/&D4=I/6RVQC);):$V!^FCK-\7:9I]]_]0 M2P,$% @ ;% .3V)SJ(G+G"*D>?XF"^3GH7ASXEM\(#\PI('?15I M7$@Q%7../6"R$PYH2UB"KPFC&T7MKH)PRG8>7EH@DTPJI$T7C;K((LVC#T?> MLPWN>3@54KGYDD&ZER4&.:" ]0&C,HK!Q%R\J^M:P#&]1:9_-<^_1OCF*%M5T M*_6'UE0CG&_/#MPJ*&CG_*X8\QMV4M=L]Y[14G#PM?PR871DPC0F0QY4244? M#9\]*9D!0&&T!:5IMH]\4Z1>0Z>'T]05QVI>/D/-3]WG$@0HPO9%FZ/_/W?Y M'RL^O_QSR6ZH' I^0HWV*GD&(B_^LLB@GY5[ WDVCD<4;5K*-!6]W(KF.7@] M]CY,\!=[&;/95)RFLJ'79&/^-&;\9F\.!6F9OK4ENF"")_N3%1ZMQE7KD2+! MD_T9O#X1;,?^?(S/9[A\KL7CJJX?T?>RJ)JIM9%R M>S$8--F&E;3Y6&]9I6K6M2BI5+?B8=!L!:-YLV%,EL7 &0XG@Y+RRKJZ//2U M$ /]II8LD[RN5&%;<,?9<_-6W]XBJAH\L92NIM;00G0GZQDO)!,^E>Q&U+LM MKQZFEFVA-1>-).W87U*5LE]' 4KVM&K9L.WC84J6K*I=6B":)4C7$E%@X)JWY5J MV\Y%#1WD^WE)%;$W6"0NN*H006ZWX.8@O3CR<42PCZ[=T(T\C,@MQBE!1\N* M[G(-T@$@G7>$_.9HD"< Y,G_@B2IF^(YCA1@/$/Q B=N&FB0(P!R]#Z0GDMN MT2S4(,< Y-@L9.2FRP1KL8LCMY\3+J+?V-$;N;!:$@=H[I"/U$_>+KZ?R M(93+AV8Q$QPJ,%^%4JTY2A,W(J[7;1^=$+2-<=W,YT&Z3SMM^%0^2H/H!D=> M@'N0D&ULP[HA:>Q]NHU#'R?D _*QVMJ!OEMLR#*V8 6ZBVZ [[;&+8- M> #J8T+><0Q[!][I>MYT( LYABT$8_:V$&0AQ["%_GY20T<^DSHF9"'']$O. MGTY"'2'E1:._B3F0A1S#%OKM3/2&&%$A=$S(0DYGH<'ARU#.UKQB>:2&:%1Y M1HML(5![V9]01^-6%NM=47BJ+*["FG;?&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/% MV#UN@T 0AN&K6!S RXS_(]M5&K=)+K#"8T#F3[L;Q;Y]"$VP9.^DL+XT( 2: M>:M'P/9-*AO*MO%%V?G)I:X:OTN*$+H78WQ62&W]M.VDZ>^<6E?;T%^ZW'0V M.]M<#*?ITKCQC&2_'<^<'(Z[Q!V.E$P^K,LE[!)SJ#">:]@OZ M1ZZ=_&5]>SJ5F;RVV6#.![$\*!9/&@&#YK'@^;PH$4\: $/ M6L:#EO"@53QH!0]:QX/6\*!-/&@##Z)4D3'%)VE8X[4FA6O">TT*V(07FQ2R M"6\V*6@37FU2V":\VZ3 37BY2:&;\':3@C?A]69%;\;KS8K>_ _OVMK+-EYO M5O1FO-ZLZ,UXO5G1F_%ZLZ(WX_5F16_&Z\V*WHS7FT=Z^\(Z.;X'5S:Y?W;) MS?"'7]LCN'VX5O+\C&'JP_TCI4._1G8(! #"$@ $P %M#;VYT96YT7U1Y<&5S72YX;6S-F-UN MPB 4@%^EZ>UB$;:YGZ@WVVXWD^T%&)Q:(G\!=/KVHU67S'2)BYJ6)B^IH@_ 96P MDM%5;'@ ^9Z"LO,=[XR'],I-3DS6FOR:4%V.(VTT] -TD7-63OE:0%^I+K!] MTI,*[F^#< $&/N1H2*IG>QEIEJ.1M!//N45HKXX$>53QG/IR'_;+A47WWG?@ M/\%(NN:T4S\?!T/"<8V$XP8)QRT2CA$2CCLD'/=(.!Z0<- A%A L1J58E$JQ M.)5BD2K%8E6*1:L4BUD !D;V-0&UL4$L! A0#% @ ;% .3^E)@1[N *P( !$ M ( !F0$ &1O8U!R;W!S+V-O&UL4$L! A0#% @ ;% .3YE&PO=V]R:W-H965T&UL4$L! A0#% @ ;% .3_MN:*%V M! (!4 !@ ( !\PL 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ;% .3SKP:*S0 P LQ !@ M ( !H!@ 'AL+W=O5MZ$;0! #2 P & M @ &*'@ >&PO=V]R:W-H965T&UL4$L! A0# M% @ ;% .3S48A$2T 0 T@, !@ ( !=" 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ ;% .3UHB_\:V 0 T@, !D M ( !'R@ 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ ;% .3Q6 G28D @ ! < !D ( !X2T 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ ;% .3\O) MP^FU 0 T@, !D ( !%S0 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ;% .3RU'%4?_ 0 , 4 !D M ( !T#H 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ ;% .3T@OG'W@ 0 R@0 !D ( ! M/T$ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ ;% .3SMV5R4+ P /PT !D ( !.DD 'AL+W=O7!E <&UL4$L%!@ E "4 ]0D ,* $! end XML 41 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 42 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 43 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 49 224 1 false 24 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://nhf.com.my/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED BALANCE SHEETS (Unaudited) Sheet http://nhf.com.my/role/CondensedBalanceSheets CONDENSED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://nhf.com.my/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://nhf.com.my/role/CondensedStatementsOfOperations CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://nhf.com.my/role/CondensedStatementsOfCashFlows CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN Sheet http://nhf.com.my/role/NatureOfOperationsBasisOfPresentationAndGoingConcern NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN Notes 6 false false R7.htm 00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://nhf.com.my/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 00000008 - Disclosure - PROPERTY, PLANT AND EQUIPMENT Sheet http://nhf.com.my/role/PropertyPlantAndEquipment PROPERTY, PLANT AND EQUIPMENT Notes 8 false false R9.htm 00000009 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES Sheet http://nhf.com.my/role/AccountsPayableAndAccruedExpenses ACCOUNTS PAYABLE AND ACCRUED EXPENSES Notes 9 false false R10.htm 00000010 - Disclosure - PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS Sheet http://nhf.com.my/role/PayableToAffiliatesAndDrawdownsOfShortTermBorrowings PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS Notes 10 false false R11.htm 00000011 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://nhf.com.my/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 11 false false R12.htm 00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://nhf.com.my/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 12 false false R13.htm 00000013 - Disclosure - STOCKHOLDERS' DEFICIT Sheet http://nhf.com.my/role/StockholdersDeficit STOCKHOLDERS' DEFICIT Notes 13 false false R14.htm 00000014 - Disclosure - SUBSEQUENT EVENTS Sheet http://nhf.com.my/role/SubsequentEvents SUBSEQUENT EVENTS Notes 14 false false R15.htm 00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://nhf.com.my/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 15 false false R16.htm 00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://nhf.com.my/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://nhf.com.my/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 00000017 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables) Sheet http://nhf.com.my/role/PropertyPlantAndEquipmentTables PROPERTY, PLANT AND EQUIPMENT (Tables) Tables http://nhf.com.my/role/PropertyPlantAndEquipment 17 false false R18.htm 00000018 - Disclosure - PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS (Tables) Sheet http://nhf.com.my/role/PayableToAffiliatesAndDrawdownsOfShortTermBorrowingsTables PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS (Tables) Tables http://nhf.com.my/role/PayableToAffiliatesAndDrawdownsOfShortTermBorrowings 18 false false R19.htm 00000019 - Disclosure - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN (Details Narrative) Sheet http://nhf.com.my/role/NatureOfOperationsBasisOfPresentationAndGoingConcernDetailsNarrative NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN (Details Narrative) Details http://nhf.com.my/role/NatureOfOperationsBasisOfPresentationAndGoingConcern 19 false false R20.htm 00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://nhf.com.my/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://nhf.com.my/role/SummaryOfSignificantAccountingPoliciesTables 20 false false R21.htm 00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://nhf.com.my/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://nhf.com.my/role/SummaryOfSignificantAccountingPoliciesTables 21 false false R22.htm 00000022 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details) Sheet http://nhf.com.my/role/PropertyPlantAndEquipmentDetails PROPERTY, PLANT AND EQUIPMENT (Details) Details http://nhf.com.my/role/PropertyPlantAndEquipmentTables 22 false false R23.htm 00000023 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative) Sheet http://nhf.com.my/role/AccountsPayableAndAccruedExpensesDetailsNarrative ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative) Details http://nhf.com.my/role/AccountsPayableAndAccruedExpenses 23 false false R24.htm 00000024 - Disclosure - PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS (Details) Sheet http://nhf.com.my/role/PayableToAffiliatesAndDrawdownsOfShortTermBorrowingsDetails PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS (Details) Details http://nhf.com.my/role/PayableToAffiliatesAndDrawdownsOfShortTermBorrowingsTables 24 false false R25.htm 00000025 - Disclosure - PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS (Details Narrative) Sheet http://nhf.com.my/role/PayableToAffiliatesAndDrawdownsOfShortTermBorrowingsDetailsNarrative PAYABLE TO AFFILIATES AND DRAWDOWNS OF SHORT TERM BORROWINGS (Details Narrative) Details http://nhf.com.my/role/PayableToAffiliatesAndDrawdownsOfShortTermBorrowingsTables 25 false false R26.htm 00000026 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://nhf.com.my/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://nhf.com.my/role/RelatedPartyTransactions 26 false false R27.htm 00000027 - Disclosure - STOCKHOLDERS' DEFICIT (Details Narrative) Sheet http://nhf.com.my/role/StockholdersDeficitDetailsNarrative STOCKHOLDERS' DEFICIT (Details Narrative) Details http://nhf.com.my/role/StockholdersDeficit 27 false false R28.htm 00000028 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://nhf.com.my/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://nhf.com.my/role/SubsequentEvents 28 false false All Reports Book All Reports nhel-20190630.xml nhel-20190630.xsd nhel-20190630_cal.xml nhel-20190630_def.xml nhel-20190630_lab.xml nhel-20190630_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/currency/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true ZIP 45 0001214659-19-005219-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-19-005219-xbrl.zip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